Brochure

Transcrição

Brochure

Lisbon, Portugal
September 26-30
CIRSE 2015
PRELIMINARY PROGRAMME
ANNUAL MEETING AND POSTGRADUATE COURSE
30
ye a rs
Cardiovascular and Interventional Radiological Society of Europe
I N N OVAT I O N | E D U C AT I O N | I N T E R V E N T I O N
Facts & Figures CIRSE 2014:
6,432 Participants
78 Countries
1,275 Abstracts
250 Hours of Education
98 Exhibitors
5,800 m² of Technical Exhibition
572 Unique Live-Stream Viewers
www.cirse.org
0
3
E
S
R
C
30
SE
CyeR
a rs
30
Cye aRSE
rs
ye a rs
30th ANNUAL MEETING AND
POSTGRADUATE COURSE
Contents
General Information
2
4
6
58
59
61
62
65
67
Committees / Welcome Address
Excellence in Interventional Radiology
Dignitaries
General Information
Registration
Exhibitors
Destination Lisbon
Accommodation
City Map
Scientific Programme
16
20
24
26
28
29
30
32
33
34
35
Preliminary Faculty
Session Types and Main Themes
IDEAS
Venous Interventions
Multidisciplinary Expert Boards
Controversies in Arterial Intervention
Evidence Fora
Hot Topic Symposium – Paediatric IR
The X-Session
Radiographer Programme
CIRSE meets China
Foldout Timetable
37
40
The Preliminary Programme CIRSE 2015
If you have any queries or comments,
please contact us at [email protected]
© Cardiovascular and Interventional
Radiological Society of Europe / 2015
Graphic Design: LOOP.ENTERPRISES media EU
www.loop-enterprises.com
Cover: Palácio Nacional da Pena © Shutterstock
Print: Druckerei Janetschek GmbH
Heidenreichstein / Austria
Hands-on Workshops
Programme
2
Committees / Welcome Address
CIRSE Committees
Executive Committee
Local Host Committee
Anna-Maria Belli (UK), President
Elias Brountzos (GR), Vice-President
Robert A. Morgan (UK), Treasurer
Michael J. Lee (IE), Past President
Mario Bezzi (IT)
Christoph A. Binkert (CH)
Thierry de Baère (FR)
Élia Coimbra (PT)
Afshin Gangi (FR)
Patrick Haage (DE)
Klaus A. Hausegger (AT)
Thomas J. Kroencke (DE)
Stefan Müller-Hülsbeck (DE)
Dierk Vorwerk (DE)
Daniel Waigl (AT)
Élia Coimbra (Lisbon), Chairperson
Belarmino Gonçalves (Porto), SPC Representative
Paulo Almeida (Viseu)
Fernando Alves (Coimbra)
Tiago Bilhim (Lisbon)
João Filipe Costa (Coimbra)
Vasco Garcia (Lisbon)
Alfredo Gil-Agostinho (Coimbra)
Afonso Gonçalves (Lisbon)
Antonio M. Madureira (Porto)
Maria J. Martins de Sousa (Porto)
Antonio Miranda Rodrigues (Porto)
Tiago Pereira (Porto)
A. Manuel Ribeiro (Porto)
Hugo Rio Tinto (Lisbon)
Luis Rosa (Lisbon)
Pedro Sousa (Vila Real)
Paulo Vilares Morgado (Porto)
Scientific Programme Committee
Hands-on Workshop Co-ordinators
Patrick Haage (DE), Chairperson
Christoph A. Binkert (CH), Deputy Chairperson
Anna-Maria Belli (UK)
Mario Bezzi (IT)
Saruhan Cekirge (TR)
Marco Das (NL)
Thierry de Baère (FR)
Afshin Gangi (FR)
Belarmino Gonçalves (PT)
Alexis D. Kelekis (GR)
Antonin Krajina (CZ)
Riccardo Lencioni (IT)
Olivier Pellerin (FR)
Raman Uberoi (UK)
Otto M. van Delden (NL)
Christoph A. Binkert (CH), Head of Hands-on Workshops
Jocelyn A. Brookes (UK)
Lukas Hechelhammer (CH)
Thomas K. Helmberger (DE)
David O. Kessel (UK)
Antonio Martínez de la Cuesta (ES)
Levent Oguzkurt (TR)
Jai V. Patel (UK)
Jost P. Schaefer (DE)
Raman Uberoi (UK)
Jos C. van den Berg (CH)
C RSE
3
Anna-Maria Belli
CIRSE President
Patrick Haage
Committee Chairperson
Christoph A. Binkert
Committee Deputy
Chairperson
Élia Coimbra
CIRSE 2015 Local Host
Committee Chairperson
Belarmino Gonçalves
CIRSE 2015 Local
Host Committee
SPC Representative
Dear Colleagues,
Once again, we find ourselves returning to Lisbon to celebrate
the biggest IR event of the year. This year, however, we will
have more than one event to celebrate: not only will CIRSE
be launching the first Interdisciplinary Endovascular Aortic
Symposium (IDEAS), but it will also be celebrating its 30 th birthday, and we look forward to seeing a good turn-out of friends
old and new.
Why Lisbon?
Previous annual meetings have shown that Lisbon is an ideal
place to host a congress of this scale. Its popularity as a tourist destination makes it easily accessible, with multiple flights
available daily, and provides us with ample hotel space and
excellent transport facilities. The famed "City of Explorers"
offers an inspiring venue for us to explore new scientific
territories, and chart how far we’ve come in the last 30 years.
High-quality education
CIRSE places great emphasis on investing in high-quality
educational and scientific programmes that offer true value
to participants. The outstanding reviews of CIRSE 2014 underscore the wisdom and success of that approach. Over 91% of
delegates indicated that the sessions on offer fully met their
specified learning objectives – the highest rate ever achieved.
Introducing young practitioners to IR and encouraging them
to hone their skills in the subspecialty is another major priority.
The Fundamental Courses, which are targeted primarily at
radiologists-in-training and new consultants, are clearly
achieving that goal. Over 97% of delegates indicated that they
learned from these sessions, and 95% deemed the information
presented relevant to their practice needs.
Other specialised sessions also garnered impressive praise,
with over 98% of participants characterising the two
well-attended Evidence Fora, Abdominal Aorta and Thoracic
Aorta, as valuable learning experiences.
Focus on aortic interventions
The evident interest in EVAR and TEVAR inspired the introduction of a new feature that will make its debut at CIRSE 2015:
the Interdisciplinary Endovascular Aortic Symposium (IDEAS).
A two-and-a-half-day stand-alone programme featuring
14 hours of targeted education, IDEAS will run in the same
building as, and parallel to, the Annual Meeting. Delegates
who have registered for either event will be able to attend
these specialised sessions and the CIRSE 2015 industry
exhibition.
Scientific highlights
Interdisciplinary collaboration is an essential part of modern
medical practice, and we are committed to welcoming
practitioners from other specialties to our Annual Meetings.
The Multidisciplinary Expert Boards, which draw on the
collaborative tradition of tumour boards, feature stimulating interdisciplinary exchanges on commonly encountered
challenges in the oncological and vascular fields.
Good practice can only be achieved – and maintained – by
ongoing debate and critical evaluation. To this end, Hot Topic
Symposia on both aortic intervention and paediatric interventions are planned, as are a number of Controversies sessions
addressing radiation safety, arterial intervention and venous
disease. To ensure that best practice is decided based on
clinical data, the popular Evidence Fora will examine the use of
peripheral angioplasty and drug-eluting devices.
Other programme highlights for CIRSE 2015 include four
Venous Fora, tackling diverse aspects of venous inter ventions.
The high turnout for 2014’s session on DVT and PE suggests
these will be particularly attractive to our delegates.
Our "CIRSE Meets…" session will host a delegation from
China, and we look forward to learning how the discipline is
developing in the Far East.
Celebrate 30 years of CIRSE!
CIRSE 2015 marks the organisation’s 30 th anniversary, and
our celebrations will include a one-off event, the X-Session,
presented by six former CIRSE presidents, who will recall
important formative moments from their clinical careers, and
reflect on how the field of IR has grown and progressed since
their early involvement.
Lisbon offers a great opportunity to celebrate our diverse
community and explore our growing specialty, and promises
to be a congress to remember.
Come celebrate 30 years of excellence in IR with us in Lisbon!
Lisbon 2015 | Annual Meeting and Postgraduate Course
4
Preliminary Programme
CIRSE Gold Medallists
Gruentzig Lecture
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
J. Roesch
J.H. Peregrin
J.I. Bilbao
P.R. Mueller
J.A. Reekers
F.S. Keller
J. Lammer
J.E. Abele, B. Cook
A. Adam
B.T. Katzen
J.F. Reidy
J.L. Struyven
C.L. Zollikofer
J.H. Göthlin, J.-J. Merland, E.P. Zeitler
E. Boijsen, F. Olbert, F. Pinet
P. Rossi
A.M. Lunderquist
D.J. Allison
R.W. Günther
CIRSE Distinguished Fellows
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
1993
1992
1991
1990
1989
1988
R. Lencioni, K. Malagari, H.I. Manninen, G.-J. Teng
M.D. Dake, J.G. Moss, D. Siablis
J.B. Spies, B.S. Tan, P.R. Taylor
G.M. Richter, M. Szczerbo-Trojanowska, K.R. Thomson
J.A. Kaufman, L. Machan, A.F. Watkinson
O. Akhan, W.P.T.M. Mali
A.A. Nicholson, A.C. Roberts
K. Mathias, H.P. Rousseau
K.H. Barth, D.A. Kelekis
A. Rosenberger, G. Simonetti
F.S. Keller, A.J. Roche
A. Besim, B. Läubli, P.R. Mueller, R. Yamada
K. Hiramatsu, F. Joffre, H. Uchida
C. L‘Herminé, J.-M. Rius, M.R. Dean
J.-M. Bigot, J. Edgren
J.-C. Gaux, L. Horváth
U. Tylén
A.R. Essinger
J.H. Göthlin, J.L. Struyven
M.J. Amiel, P. Rossi
U. Erikson
D.J. Allison
E.P. Zeitler
I.P. Enge, A.M. Lunderquist, F. Olbert
A. Pinet, F. Pinet
A. Baert, L. Di Guglielmo, G. Van Andel
J.-L.M. Lamarque, R. Passariello
E. Boijsen, C.B.A.J. Puylaert, E. Voegeli
G. Soulez
P.L. Pereira
A. Holden
A. Gangi
J.G. Moss
D. Vorwerk
R. Lencioni
C. Becker
J.C. Palmaz
L. Solbiati
A.C. Roberts
E.P.K. Strecker
K.R. Thomson
P.A. Gaines
B.T. Katzen
J.L. Struyven
S. Wallace
R.W. Günther
P. Rossi
J. Roesch
D.J. Allison
E.P. Zeitler
Roesch Lecture
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
J.A. Reekers
F.C. Carnevale
M. Bezzi
D. Pavčnik
M. Szczerbo-Trojanowska
J.I. Bilbao
M.D. Dake
J.A. Kaufman
K. Ivancev
L. Machan
H.P. Rousseau
F.S. Keller
J. Roesch
Award of Excellence and Innovation in IR
2014
2013
2012
M.G.E.H. Lam, J.F.W. Nijsen, M.A.A.J. van den Bosch
S. Lerouge, G. Soulez
A. Bolia, J.A. Reekers
C RSE
The Award of Excellence and
Innovation in IR
Innovative Spirit
During CIRSE 2014, the R.W. Günther Foundation honoured the innovation of a multidisciplinary
research team from Utrecht, the Netherlands, for their innovative work in developing Holmium-166
microspheres, the first radioactive microspheres that can be visualised in vivo on multimodal
imaging.
Development
The continuous development and refinement of new agents, devices and techniques by resourceful
interventional radiologists will further expand the remarkable spectrum of treatments offered by our
specialty.
Recognition
Innumerable patients are grateful for the wide range of minimally invasive alternatives to open
surgery from which they can now benefit. Furthermore, CIRSE also wishes to honour your dedication
and excellence in IR and present your innovation to the IR community during the opening ceremony
of CIRSE 2015.
Recipients of this distinction will be awarded with a certificate of merit
for their contributions to the field, as well as a cash prize of €5,000.
How to apply
Send us your groundbreaking research results, details of a novel technique you developed, or
the cutting-edge equipment you have just patented. Our board of reviewers welcomes all your
innovations and looks forward to the advances they may bring to IR.
R.W. Günther Foundation
We warmly thank the R.W. Günther Foundation for kindly sponsoring the award. The Foundation is
based in Aachen, Germany and aims to promote science and research, especially in the field of
radiological sciences and diagnostic and interventional radiology, as well as to support national
and international co-operation.
Please note that all applications must be submitted with a relevant CV or,
in the case of research groups, a description of the members involved.
All applications must be submitted by May 28, 2015 to [email protected].
For more information, please visit the CIRSE website.
6
Dignitaries
Distinguished Fellow
Riccardo Lencioni
Riccardo Lencioni, Professor and Director of Diagnostic
Imaging and Intervention at the Pisa University School of
Medicine, Italy, is one of the world’s foremost interventional
oncology specialists, and is particularly well-known for his
influential work on liver cancer.
In 1994, while still a radiology resident, Prof. Lencioni
published the first European study on the combined use of
chemoembolisation and ethanol injection for the treatment
of hepatocellular carcinoma (HCC), in Cardiovascular and
Interventional Radiology. This was followed one year later by his
seminal work on prognostic factors for HCC patients treated
with local ablation. The criteria for identifying long-term
survivors, published in his 1995 paper in Cancer, were
confirmed as the best outcome predictors for liver transplantation, and are currently accepted worldwide for defining
early-stage HCC.
Prof. Lencioni has always been on the cutting edge of research
in interventional oncology. He conducted the first randomised
controlled trial on the use of radiofrequency ablation for
HCC in 2003, and the first intention-to-treat analysis of longterm survival of treated patients in 2005. The results of these
studies led to the recognition of image-guided ablation as the
standard of care for non-surgical patients with early-stage
HCC in international guidelines. Riccardo Lencioni also
launched the first programme on RFA of lung tumours in
Europe, culminating in the publication of the first international,
multicentre trial on the topic in The Lancet Oncology in 2008.
With the advent of molecular-targeted agents in cancer
treatment, Riccardo Lencioni has opened a new chapter
in clinical research, focusing on investigating the potential
synergies between these novel therapeutic options and
interventional techniques. He was the principal investigator
for the two largest multicentre randomised controlled
trials assessing the clinical benefits of innovative regimens,
including combinations of systemically-active drugs and locoregional therapies. With more than 1,000 patients recruited
at nearly 200 sites worldwide, these studies, both recently
completed, represent the very first global clinical studies ever
conducted in the field of interventional oncology.
Riccardo Lencioni was also part of the research group
that showed, for the first time in medical history, that a
genetically-engineered virus injected directly into a tumour
via an image-guided percutaneous approach has the potential
to improve survival in cancer patients, in a study published in
Nature Medicine in 2013. He is also well-known for being the
lead author of the modified RECIST criteria (mRECIST) for the
evaluation of tumour response in HCC.
His scientific contributions have received considerable
international recognition, including awards for the most-cited
publications from the editors-in-chief of European Radiology
and Cardiovascular and Interventional Radiology, for his
ground-breaking papers on RFA of liver metastases and
chemoembolisation with drug-eluting beads. He has been an
honorary lecturer at several conferences, including at CIRSE
2009 and ECIO 2014.
Prof. Lencioni is actively involved with numerous scientific
societies and organisations, including CIRSE, SIR, EAR, ECR,
RSNA, WCIO, ESGAR, ILCA and SIRM. He has held numerous
offices within CIRSE, including as Chairman of the Standards of
Practice Committee, Chairman of the Membership Committee,
and ECIO Programme Committee Chairman from 2008 to
2013. He currently serves as Chairman of the WCIO. In 2007, he
co-founded the International Liver Cancer Association, of which
he is the Executive Secretary.
In addition, Riccardo Lencioni has authored 182 articles in
peer-reviewed, international journals indexed in PubMed, as
well as numerous chapters in textbooks on interventional
radiology, gastroenterology, oncology and surgery. He has also
served as editor of nine books, including the landmark volume
“Embolization Therapy: Principles and Clinical Applications”,
published in 2015. According to the SCOPUS database,
his publications have been cited in international scientific
literature over 13,000 times, amounting to an h-index of 53.
CIRSE Opening and Awards Ceremony
Riccardo Lencioni will be awarded on
Saturday, September 26, 14:30-16:00
Dignitaries
Katerina Malagari
Katerina Malagari is an associate professor of radiology in the
IR division of the Department of Radiology at the University of
Athens, in Greece. She pursued her undergraduate studies at
the university’s medical school. Dr. Malagari also completed
her residency in radiology in Athens, and was board certified
in 1990. Two years later, she obtained her Ph.D. from the
University of Athens.
Dr. Malagari completed various fellowships, including one
in Chest at the University of Alabama at Birmingham, and
a fellowship in interventional radiology at the University of
Athens. She obtained her EBIR certification in 2010.
Her clinical and research interests centre on embolisation, with
a special focus on interventional oncology. She is currently
part of Prof. Dimitris Kelekis’s research team, working with Dr.
Mary Pomoni at Evgenidion Hospital and Attikon University
Hospital, which is chaired by Dr. Nikolaos Kelekis. She also
actively contributes to efforts to develop scientific protocols
for research in interventional oncology, and is part of the
National Referral Centre for Liver Diseases and Hepatocellular
Carcinoma of Greece.
Her publications focus on chemoembolisation of HCC, with
recent articles assessing the response of HCC to transarterial
chemoembolisation with mRECIST criteria and contrastenhanced US, the safety and efficacy of chemoembolisation of
HCC with Hepasphere 30-60 μm, and chemoembolisation with
doxorubicin-eluting beads for unresectable HCC.
Dr. Malagari is an active member of various multidisciplinary
committees and of several international societies, including
CIRSE, SIR, the Αmerican Roentgen Ray Society, and the
European Society of Thoracic Imaging, serving as President of
the latter’s Annual Meeting in 2007. She contributed to CIRSE’s
quality assurance guidelines for the endovascular treatment
of occlusive lesions of the subclavian and innominate arteries,
served on the Scientific Programme Committee for ECIO
2013, and has given numerous presentations at CIRSE Annual
Meetings and ECIO and GEST conferences.
Her work has been recognised with the Best Scientific Paper
award at ESTI 2005. She was also part of the team awarded the
CVIR’s Editor’s Medal in 2012.
An editorial board member of CVIR, Dr. Malagari is also an
active reviewer for various other scientific journals, including
Hepatology, Hepatogastroenterology, European Radiology, Chest
and European Respiratory Journal. She has also contributed to
sixteen books, distributed both in Greece and internationally,
and has published 107 articles in peer-reviewed journals.
Katerina Malagari will be awarded on
7
8
Dignitaries
Hannu I. Manninen
Hannu Manninen graduated high school in Hankasalmi,
Finland. He completed his M.Sc. degree in medical physics
and his M.D. degree at the University of Kuopio in 1980.
He finalised his thesis in diagnostic radiology in 1985 and
completed his residency in Kuopio University Hospital in 1987.
He was appointed head of the 1st Department of Radiology
at Kuopio University Hospital in 1989. In 2004, he was both
promoted to chairman of the entire radiology clinic, and
became Professor of Interventional Radiology at the University
of Eastern Finland.
His main clinical expertise is in cardiovascular imaging and a
wide range of interventional radiology. He began performing
coronary and general vascular interventions in the late 1980s
and now predominantly performs aortic and neuroradiological
interventions.
Professor Manninen is the author or co-author of more than
150 peer-reviewed original publications and he has written
20 reviews or book chapters, mainly focused on cardiovascular
imaging and interventional radiology. For more than 25 years,
his main areas of scientific interest have been endovascular
therapies for peripheral ASO, including pioneering prospective
studies of infrapopliteal PTA and gene therapy. He has been
the principal investigator in two prospective randomised trials,
comparing hysterectomy with endovascular embolisation of
uterine leiomyomas and evaluating the placement of drugeluting stents with bypass surgery for treatment of femoropopliteal ASO. Recently he has also focused on aortic
interventions and novel techniques for treatment of
intracranial aneurysms and acute stroke. He has been the
principal supervisor in nine completed theses and has been a
reviewer of eight theses in several Finnish universities.
Professor Manninen’s committee appointments include
membership of the Board of Administration of the Radiological
Society of Finland from 1996-1998, Vice-President from
2001-2003 and President from 2004-2005. He has also been
an adminstrative member of the Finnish Medical Society
Duodecim from 1995-1997 and the Finnish Society of
Angiology from 1995-2002. He was a member of the Council of
Medical Faculty of Kuopio University from 2001-2003 and
a president of Finnish Society of Interventional Radiology from
1997-1998. Professor Manninen is also EBIR-certified and a
CIRSE Fellow. He was the local chairman of the first advanced
ESIR course on vascular interventions, held in Kuopio in
2008, and since 1996, has organised ten national meetings in
Kuopio University Hospital focusing on vascular imaging and
interventions, including lectures and live cases transmitted
from angio-suites and operating theatres. He has also held
numerous hands-on training sessions using pig models for
small groups of young interventional radiologists in the
National Laboratory Animal Center in the University of Eastern
Finland.
Professor Manninen is married to Pirjo, who is a specialist in
occupational medicine, and they have two adult children, Otto
and Elina. In his free time, he enjoys an outdoor life, which
includes gardening together with Pirjo as well as forestry in his
small forest estate. During the summer, he practices rowing
at Lake Kallavesi and during the long snowy winter of Kuopio,
cross-country as well as off-track skiing. His passion for saunas
exceeds even Finnish norms and he daily warms up one of the
four saunas of his house or summer cottage.
He was a member of Editorial Board of European Radiology
from 2002-2007, Acta Radiologica in 2004, and Cardiovascular
and Interventional Radiology since 2008.
Hannu I. Manninen will be awarded on
Dignitaries
Gao-Jun Teng
Dr. Gao-Jun Teng is a professor and the Chair of Radiology and
Vascular Surgery at Zhongda Hospital, Southeast University in
Nanjing, China.
Dr. Teng graduated from medical school in 1982, and completed his radiology residency and interventional radiology
fellowship training in 1986 and 1987 respectively. His strong
research interests led him to complete his MSc and PhD
degrees soon after. From July 1995 to March 1998, he was a
research fellow at the Division of Interventional Radiology at
the Dartmouth-Hitchcock Medical Centre, under Dr. Michael
Bettmann’s mentorship.
At the time of Dr. Teng’s residency, interventional radiology
had only just been introduced to China. After a mini-fellowship
with Dr. Zhijiang Liu, one of the nationally recognised pioneers,
Dr. Teng decided to pursue a career as an interventional
radiologist in 1987. As the first interventional radiologist at
Zhongda Hospital of Southeast University, he began his IR
career with interventional oncology. In addition to the interventional oncological procedures, he performed many "first
interventional procedures" at Zhongda Hospital, including
transcatheter embolisation for gastroenteral bleeding and
haemoptysis, PTA/stenting for renal arterial stenosis, treatment
of Budd-Chiari syndrome, TIPS, percutaneous discectomy,
percutaneous vertebroplasty, stent grafting for AAA and aortic
dissection, IVC filter placement, and RF, cryo- and microwave
ablation of tumours.
During his career, Dr. Teng has developed several new techniques and devices, including a unique radioactive stent
system for oesophageal carcinoma and biliary tract malignancies, respectively, with a phase 3 trial published in Lancet
Oncology, and a new spiral automated lumbar nucleotome
that has been used to treat thousands of patients in China. As
a research fellow in Dartmouth-Hitchcock Medical Centre, Dr.
Teng was involved in the mechanism study of TIPS restenosis.
They verified the role of bile leak in TIPS restenosis, which contributed to the theory of successful use of a covered stent in
TIPS. As a radiologist, Dr. Teng has also been involved in many
diagnostic radiology research fields, especially in MR molecular
imaging and fMRI.
To optimise patient safety and clinical practice, Dr. Teng
created a dedicated interventional radiology in-patient floor in
the 1990s. He merged vascular surgery into his interventional
radiology unit in 2000s. This new practice has since become
one of the standard models of IR practice.
Dr. Teng is an active researcher. He has authored or
co-authored more than 300 publications featured in Lancet
Oncology, PNAS, Radiology, Journal of Hepatology, Diabetes,
CVIR, JVIR, etc. as well as 10 Chinese book chapters. He has
delivered hundreds of lectures and scientific presentations
nationally and internationally. He has also hosted many
Chinese scientific conferences, and was co-chairman of the
CIRSE meets China session at the CIRSE 2007 annual meeting.
Over the last decade, Dr. Teng has served as editor and
associate editor for many journals, including CVIR and Chinese
JVIR.
Over the past two decades, he has mentored over 60 MSc and
30 PhD candidates, many of whom have since became local or
national leaders in the field of interventional and diagnostic
radiology. As dean of a medical school, he has taught hundreds
of medical school students, and more than 100 residents and
fellows in his department.
Since 1998, Dr. Teng has held the position of Chairman of
Radiology at Zhongda Hospital of Southeast University,
Nanjing, China. He was the dean of the Medical School of
Southeast University from 1999 to 2014. Since the beginning of
2015, he has been President of Zhongda Hospital.
Dr. Teng was President of the Chinese Society of Interventional
Radiology (CSIR) during the term 2009-2011, and is currently
the vice-president of the Chinese Society of Radiology, and
president-elect of the Asia-Pacific Society of Cardiovascular
and Interventional Radiology (APSCVIR) for the term 2014-2016.
Dr. Teng has been a fellow of SIR (FSIR) since 2008 and a fellow
of CIRSE since 2013.
Gao-Jun Teng will be awarded on
9
10
Dignitaries
Dignitaries
Gold Medallist
Josef Roesch
Josef Roesch, Professor of Interventional Radiology at the
Dotter Interventional Institute of Oregon Health & Science
University (OHSU), in Portland, Oregon was born in Pilsen,
Czechoslovakia (today the Czech Republic) in 1925. He earned
his medical degree at Charles University in Prague in 1950,
then completed his radiologic training at the Central Military
Hospital in Prague, where he worked until 1967. Dr. Roesch
began his angiographic career with transparietal splenoportography in 1954, later adding visceral angiography.
While in Prague, he wrote two monographs: Transparietal
Splenoportography and Radiology of Spleen and Pancreas. The
latter became a prime teaching book, and was translated into
four languages. He became Doctor of Medical Sciences at
Charles University in Prague in 1965, and Docent in 1966.
In 1967, Dr. Roesch moved to the USA following an invitation
from Dr. Charles Dotter. Aside from a two-year visiting
professorship at UCLA, he has worked at OHSU ever since.
At OHSU, he served as Chief of Cardiovascular Radiology and,
in the late 1980s, was instrumental in establishing the Dotter
Interventional Institute, of which he was the Founding Director
until 1993. Dr. Roesch retired from clinical practice in 1995, and
has since focused on research and education.
His research has covered diverse aspects of vascular and
interventional radiology, from super-selective catheterisation
techniques, visceral angiography and transjugular liver procedures to coronary angiography, local thrombolysis, fallopian
tube recanalisation and expandable stents. An innovator in
his field, Dr. Roesch developed the TIPS techniques in 1969,
and introduced embolisation of gastrointestinal haemorrhage
in 1972. In the 1980s, his research focused on the use of
endoluminal prostheses, including their use in TIPS. His work
helped introduce TIPS to clinical practice. In the 1990s, he
worked on the wide popularisation of TIPS, and, with his research team, focused on improving the TIPS technique. Their
experimental work on covered stents contributed to the wide
clinical expansion and durability of the TIPS procedures.
A prolific writer, Dr. Roesch has authored or co-authored
493 scientific papers and book chapters, two books, and
23 scientific exhibits; contributed to 17 teaching films/videos
and CDs; and served as co-editor of two books. Dr. Roesch has
also been very involved in providing interventional education
and training using advanced technology. In addition, he has
been active in organising national and international symposia,
and served as the chairman of twelve conferences held in
Portland and Prague.
Roesch is a fellow of both CIRSE and SIR, an honorary fellow
of the ACR, a member of the RSNA and the American Heart
Association, and an honorary member of the Royal Belgian
Radiological Society, the British Institute of Radiology, the
Japanese Radiologic Society, the Czech Radiological Society
and the Czech Society of Hepatology.
His work has been recognised with many awards, including
gold medals from the European Association of Radiology
in 1991, the Japanese Society of Cardiovascular and
Interventional Radiology in 1994, SIR in 1997 and the Western
Angiographic and Interventional Society in 2000. In addition,
he was asked to present CIRSE’s Andreas Gruentzig Lecture
in 1996, and was awarded lifetime achievement awards from
CIRSE and the Czech Radiological Society in 1999, the same
year he also received the AHA Distinguished Achievement
Award. Dr. Roesch has also been awarded medals from Osaka
City University, the Medal Ville de Toulouse, the 650 Year
Charles University Anniversary Medal, and a medal from the
Scientific Committee of the European Association for the Study
of the Liver, in recognition of his life-long work in hepatology
and gastroenterology. He also received the Discovery Award
from the Medical Research Foundation of Oregon, the Golden
Apple and Angie awards from the Western Angiographic
Society, first scientific prizes at three International Congresses
of Radiology, and has won several awards for scientific exhibits
at RSNA, including two Magna Cum Laude awards. In addition,
Roesch received a Distinguished Scientist Award from the AHA
in 2004, and the SIR Foundation Leaders in Innovation Award
in 2006.
The OHSU established a research professorship, the Josef
Roesch Chair of Interventional Radiology Research, in his
honour. In addition, both CIRSE and the Society of
Interventional Radiology of the Czech Republic have honoured
Dr. Roesch with eponymous lectures bearing his name at their
annual meetings.
Josef Roesch will be awarded on
11
12
Interdis c ip linar y
Endovascular
Aortic Symposium
Hands-on Workshops
IDEAS
2
0
1
5
September 27-29
Lisbon/Por tugal
Aortic interventions require an interdisciplinary approach
and strong teamwork. To reflect this, IDEAS brings
together noted interventional radiologists, vascular
surgeons, cardiologists and anaesthesiologists for
2.5 days of scientific education.
JOIN US AS WE EXPLORE A VARIETY OF
KEY TOPICS IN EVAR AND TEVAR, INCLUDING:
•
•
•
•
•
Current and potential future optimal imaging strategies for surveillance after EVAR
What does the evidence tell us about the management of aortic dissection?
Update on EVAR indications, devices and outcomes
Management of short necked and juxtarenal abdominal aortic aneurysms
Ruptured abdominal aortic aneurysms:
do the trials provide more questions than answers?
• Strategies for aortic arch and thoracoabdominal aneurysms
• Prevention and management of endoleaks and complications
and much more...
www.aorticideas.org
I N N O V AT I O N | E D U C AT I O N | I N T E R V E N T I O N
C RSE
Cardiovascular and Inter ventional Radiolo gical So ciet y of Europ e
Dignitaries
Gruentzig Lecturer
Gilles Soulez
Dr. Gilles Soulez is a vascular and interventional radiologist
based in Montreal. He is currently Professor of Radiology and
Chair of the Department of Radiology, Radio-oncology and
Nuclear Medicine at the University of Montreal.
A French citizen by birth, Dr. Soulez completed his medical
studies at the René Descartes University, Paris. He was
board certified in radiology in 1988 (Paris). After a two-year
fellowship in Paris, he received certification from the College of
Interventional Radiology in 1990 (Paris). He moved to Montreal
in 1991, certified as a radiologist in the province of Quebec in
1992 and continued his work and studies at the University of
Montreal, achieving an MSc in Clinical Epidemiology in 2000
and became radiology board certified at the Royal College of
Canada in 2010.
Since arriving in Canada, he has remained at the University of
Montreal, being promoted to full professor in the Department
of Radiology in 2003, and becoming the department’s chair
in June 2012. He has mentored many students in the last 20
years, including residents, fellows, graduate and post-doctoral
students, as well as involving himself in undergraduate
training.
He has funded the Research Imaging Platform at the Centre
Hospitalier de l’Université de Montréal Research Center and
was involved in multiple preclinical and clinical research
studies. His research programme is exclusively dedicated
to vascular and interventional radiology, with a particular
interest in the field of aneurysm endovascular repair,
peripheral vascular disease and advanced image guidance
for IR procedures. His research is funded by the Canadian
Institute of Health Research, Fonds de la Recherche en Santé
du Québec, Canadian Foundation for Innovation, the Natural
Sciences and Engineering Research Council of Canada and the
medical industry. He is also granted by a National Scientist
Award from the Fonds de la Recherche en Santé du Québec
since 2010.
Dr. Soulez has published 155 peer-reviewed papers, 26 book
chapters, 342 scientific abstracts and has delivered over 136
invited presentations at conferences in North America and
Europe. He is author or co-author on 9 patents in the field of
vascular and interventional radiology. He was honoured by the
Société Canadienne Française de Radiologie with the prize of
Innovation (2008) and prize Bernadette Nogrady (1997) and
by CIRSE in 2013, together with with his colleague Dr. Sophie
Lerouge, with the Award of Excellence and Innovation in
Interventional Radiology. He has received multiple prizes
for the quality of his publications at the Radiological Society
of North America, the International Society of Endovascular
Therapy, the Society of Interventional Radiology, Société
Française de Radiologie, Société Canadienne Française de
Radiologie and the Controversies and Updates in Vascular
Surgery meeting.
He serves on the evaluation committee of both the Clinical
Research Program and the Clinical Scholarship Program of the
Fonds de la Recherche du Québec en Santé, as well as being a
member of the board of the Quebec Bio-Imaging Network.
He serves on the editorial committee of the Journal de
Radiologie Diagnostique et Interventionnelle, as well as acting
as a reviewer for many English-language journals, including
Investigative Radiology, European Radiology, the American
Journal of Radiology, British Journal of Surgery, the European
Journal of Gastroenterology, the Canadian Association of
Radiologists, Cardiovascular and Interventional Radiology, the
Journal of Vascular and Interventional Radiology, the Journal of
Endovascular Therapy and Medical Physics.
Andreas Gruentzig Lecture
Advanced image modelling of abdominal aortic
aneurysm: impact on EVAR management
Sunday, September 27, 14:30-15:00
13
Submit your manuscript
to a global audience!
CVIR is the official journal of:
Austrian Society of Interventional Radiology (ÖGIR)
Brazilian Society of Interventional Radiology and Endovascular Surgery (SoBRICE)
British Society of Interventional Radiology (BSIR)
Chinese Society of Interventional Radiology (CSIR)
Czech Society of Interventional Radiology (CSIR)
Danish Society of Interventional Radiology (DFIR)
Dutch Society of Interventional Radiology (NGIR)
Finnish Society of Interventional Radiology (FSIR)
German Society of Interventional Radiology (DeGIR)
Indian Society of Vascular and Interventional Radiology (ISVIR)
Interventional Radiology Section of the Polish Medical Society of Radiology (PLTR)
Israeli Society of Interventional Radiology (ILSIR)
Japanese Society of Interventional Radiology (JSIR)
Korean Society of Interventional Radiology (KSIR)
Russian Society of Interventional Onco-Radiology (SIOR)
Swiss Society of Cardiovascular and Interventional Radiology (SSCVIR)
Turkish Society of Interventional Radiology (TGRD)
To submit a manuscript, please visit:
www.cvironline.org
00270
1
174 -155
• ISSN 0
38(1) 1-2
5)
56 (201
ogy
l
o
i
d
a
nal R
o
i
t
n
e
nter v
I
d
n
a
ular
c
v o l 3 81
s
a
V
o
i
n o b
d
r
Ca
f e
15
enti
Interv
adio
onal R
R
CV
f
The o
ardi
the C
nal of
r
u
o
j
ficial
r
Springe
ovasc
nd
ular a
lo
Socie
gical
Europ
ty of
20
e
Dignitaries
Roesch Lecturer
Jim A. Reekers
Jim Reekers completed his undergraduate medical training at
the University of Amsterdam. Inspired by the work of Charles
Dotter, he developed a special interest in interventional
radiology, and gained board certification in radiology in 1986.
After a short fellowship with Professor Allison in London, he
was appointed as staff radiologist at the Academic Medical
Center, University of Amsterdam, that same year.
Interventional radiology was still a young discipline at the
time. Dr. Reekers showed great initiative and commitment, and
studied the specialty by travelling around Europe, visiting and
learning from the famous IR innovators of the day. Publishing
his Ph.D. thesis on ‘New interventional techniques’ in 1994,
he went on to be appointed Professor of Radiology and
Interventional Radiology at the University of Amsterdam
in 1999.
Professor Reekers has been at the forefront of the IR discipline
in many different ways throughout his career: as an active
promoter of interventional techniques worldwide, as a teacher
and lecturer, and as an inventor of new interventional tools.
He invented the Hydrolyser catheter, the Optease filter and,
most recently, the Reekross catheter. His most recent research
is in the field of perfusion angiography, a new imaging tool
he developed for functional imaging of the feet of patients
suffering from CLI. He is a pioneer of subintimal angioplasty.
Much to his regret, however, his name for this new technique
(percutaneous intentional extraluminal recanalisation, or PIER)
has not been widely adopted.
A key opinion leader in the field, he played a leading role in
securing the recognition of interventional radiology as a
medical subspecialty of radiology by the UEMS. Professor
Reekers is also known for his efforts to introduce evidencebased medicine and good clinical trials into IR, and has been
the primary investigator for several randomised trials in the
field, including the recent EMMY trial on UFE.
Strongly committed to teaching and communication, Professor
Reekers wrote a successful book on ‘Presenting at Medical
Meetings’. In addition, he has actively trained many young
interventional radiologists in the Netherlands, and more than
20 doctoral theses on IR were written under his mentorship
as academic professor.
Professor Reekers acquired the EBIR in 2010, and is a fellow of
CIRSE. His long-time involvement with the society culminated
in his presidency from 2007 to 2009. He is also a fellow of
the Society of Interventional Radiology, and is a member of
the European Society of Vascular and Endovascular Surgery,
the NVvR (Dutch Society of Radiology), and the NGIR (Dutch
Society of Interventional Radiology), of which he was president
between 1998 and 2010.
His publications comprise more than 200 peer-reviewed papers
and over 30 book chapters. Professor Reekers also served on
the editorial board of the European Journal of Vascular and
Endovascular Surgery from 2001 to 2008, and is currently on
the editorial board of CVIR. In addition, he has presented more
than 250 invited international lectures, including the honorary
lecture at the Friedrich Olbert Interventional Workshop in 2007,
and the SIR’s 2008 Dotter Lecture.
Further awards include the European Congress of Radiology
Medal for best presentation (1993), the Stauffer Award from the
Society of Academic Radiology for best clinical paper (1996),
as well as honorary fellowships of both the British Society
of Interventional Radiology and the UK and Irish Society of
Vascular Surgery.
The many positions Professor Reekers holds keep him busily
working for IR. When he does have spare time, he likes to give
expression to his creativity, especially through writing, painting
and music.
Josef Roesch Lecture
CLI beyond pipe fitting
Tuesday, September 29, 14:30-15:00
15
16
Preliminary Faculty
Preliminary Faculty
as per printing date – subject to change
Adam, A. *
Åkesson, M.
Akhan, O.
Al-Kutoubi, A.M.
Almeida, P.A.M.S.
Andersson, T.
Andrašina, T.
Antonietti, A. *
Arai, Y.
Ayuso, C.
Bale, R.
Banerjee, S.
Barnacle, A.M.
Bartal, G.
Basile, A. *
Becquemin, J.-P.
Benenati, J.F.
Bérczi, V. *
Beregi, J.-P.
Bezzi, M. *
Bicknell C.
Bilbao, J.I. *
Bilhim, T. *
Binkert, C.A. *
Bize, P.E. *
Black, S.
Boatta, E.
Böckler, D.
Bonafé, A.
Bratby, M.
Breen, D.J.
Brennan, P.
Brisbois, D.A.
Brookes, J.A.
Brountzos, E. *
Bruix, J.
Buecker, A. *
Burgmans, M.C.
Buy, X.
Cahill, A.M.
Callstrom, M.R.
Cao, P.
Carnevale, F.C.
Cejna, M. *
Cekirge, S.
Černá, M. *
London/UK
Malmö/SE
Ankara/TR
Beirut/LB
Viseu/PT
Kortrijk/BE
Brno/CZ
Cuneo/IT
Tokyo/JP
Barcelona/ES
Innsbruck/AT
London/UK
London/UK
Kfar-Saba/IL
Catania/IT
Créteil/FR
Miami, FL/US
Budapest/HU
Nîmes/FR
Rome/IT
London/UK
Pamplona/ES
Lisbon/PT
Winterthur/CH
Lausanne/CH
London/UK
Rome/IT
Heidelberg/DE
Montpellier/FR
Oxford/UK
Southampton/UK
Dublin/IE
Liège/BE
London/UK
Athens/GR
Barcelona/ES
Homburg/DE
Leiden/NL
Bordeaux/FR
Philadelphia, PA/US
Rochester, MN/US
Rome/IT
São Paulo/BR
Feldkirch/AT
Ankara/TR
Olomouc/CZ
Chabrot, P.
Chalmers, N. *
Chavan, A.
Cillo U.
Cleveland, T.J.
Coimbra, É.
Crocetti, L. *
Dake, M.D.
Das, M.
de Baère, T. *
de Graaf, R.
de Gregorio, M.A. *
de Haan, M.W. *
Defreyne, L.
Denys, A. *
Deschamps, F. *
Ducasse, E.
Düx, M. *
Efstathopoulos, E.P.
Engelhorn, T.
England, A.
Fanelli, F. *
Ferro, C. *
Filippiadis, D.K. *
Fohlen, A.
Franchi-Abella, S.
Funovics, M.A. *
Gál, G.
Gandini, R.
Gangi, A. *
Garnon, J.
Gaubert, J.-Y.
Gebauer, B.
Georgiades, C.S.
Geschwind, J.-F.H.
Gibbs, R.G.J.
Gillams, A. *
Giroux, M.-F.
Glynos, M.K.
Goffette, P.P. *
Goh, G.S. *
Goldberg, N.
Golzarian, J.
Gonçalves, B.
Gould, R.
Grasso, R.F.
C RSE
Clermont-Ferrand/FR
Manchester/UK
Oldenburg/DE
Padua/IT
Sheffield/UK
Lisbon/PT
Pisa/IT
Stanford, CA/US
Maastricht/NL
Villejuif/FR
Maastricht/NL
Zaragoza/ES
Maastricht/NL
Ghent/BE
Lausanne/CH
Villejuif/FR
Bordeaux/FR
Frankfurt/DE
Athens/GR
Erlangen/DE
Salford/UK
Rome/IT
Genoa/IT
Athens/GR
Caen/FR
Le Kremlin Bicetre/FR
Vienna/AT
Odense/DK
Rome/IT
Strasbourg/FR
Strasbourg/FR
Marseille/FR
Berlin/DE
Nicosia/CY
Baltimore, MD/US
London/UK
London/UK
Montreal/CA
Athens/GR
Brussels/BE
Melbourne/AU
Jerusalem/IL
Minneapolis, MN/US
Porto/PT
Belfast/UK
Rome/IT
Preliminary Faculty
Lisbon 2015
Grunwald, I.Q.
Hacking, N.
Hamady, M.S. *
Haulon, S.
Hausegger, K.A. *
Hechelhammer, L. *
Helmberger, T.K. *
Hetts, S.
Hinchliffe, R.J.
Hohl, C. *
Huppert, P.E.
Irani, F.G.
Itkin, M.
Jackson, J.E. *
Jargiełło, T.
Jaschke, W. *
Jenkins, M.P.
Jiang, W.-J.
Kamper, L.
Karnabatidis, D. *
Katoh, M.
Katsanos, K.N. *
Katzen, B.T.
Kaufman, J.A.
Kee, S.
Kelekis, A.D. *
Kenny, L.M.
Kessel, D.O. *
Kettenbach, J. *
Kichikawa, K.
Kim, C.Y.
Kobeiter, H.
Köcher, M. *
Krajina, A. *
Krishnan, P.
Kroencke, T.J. *
Krokidis, M.E. *
Laasch, H.-U.
Lammer, J. *
Lawler, L.P. *
Lee, M.J. *
Lencioni, R. *
Liapis, C.D.
Loewe, C.M.
Lohle, P.N.M.
Lönn, L.B. *
* EBIR Diploma holders
Oxford/UK
Southampton/UK
London/UK
Lille/FR
Klagenfurt/AT
St. Gallen/CH
Munich/DE
San Francisco, CA/US
London/UK
Siegen/DE
Darmstadt/DE
Singapore/SG
Philadelphia, PA/US
London/UK
Lublin/PL
Innsbruck/AT
London/UK
Beijing/CN
Wuppertal/DE
Patras/GR
Krefeld/DE
London/UK
Miami, FL/US
Portland, OR/US
Los Angeles, CA/US
Athens/GR
Brisbane/AU
Leeds/UK
St. Pölten/AT
Nara/JP
Durham, NC/US
Créteil/FR
Olomouc/CZ
Hradec Králové/CZ
New York, NY/US
Augsburg/DE
Cambridge/UK
Manchester/UK
Vienna/AT
Dublin/IE
Dublin/IE
Pisa/IT
Athens/GR
Vienna/AT
Tilburg/NL
Copenhagen/DK
Loose, R.W.
Lucatelli, P. *
Machan, L.
Madureira, A.M.
Mahnken, A.H. *
Malagari, K. *
Maleux, G.A. *
Mangiafico, S.
Mangialardi, N.
Mani, K.
Manninen, H.I. *
Manzi, M.G.
Martínez de la Cuesta, A.
Mastracci, T.M.
Mazzaferro, V.
Mc Fadden, S.
McBride, K.D.
McCrone, P.
McPherson, S.J. *
McWilliams, R.G. *
Michel, P.
Minko, P.
Monteiro, M.P.
Morgan, R.A. *
Morse, S.
Mühlenbruch, G.
Müller-Hülsbeck, S. *
Muto, M.
Napoli, A.
Narayanan, G.
Nicholson, G.
Nienaber C.
Nilsson, A.
Oguzkurt, L. *
Orsi, F. *
Osuga, K.
O’Sullivan, G.J. *
Palena, L.M.
Palussière, J.
Paprottka, P.M.
Park, S.J.
Parodi, J.C.
Patel, J.V. *
Patel, R.
Paulo, G.
Pelage, J.-P.
17
Nuremberg/DE
Rome/IT
Vancouver/CA
Porto/PT
Marburg/DE
Athens/GR
Leuven/BE
Florence/IT
Rome/IT
Uppsala/SE
Kuopio/FI
Abano Terme/IT
Pamplona/ES
London/UK
Milan/IT
Belfast/UK
Dunfermline/UK
London/UK
Leeds/UK
Liverpool/UK
Lausanne/CH
Homburg/DE
Porto/PT
London/UK
Manchester/UK
Würselen/DE
Flensburg/DE
Naples/IT
Rome/IT
Miami, FL/US
London/UK
Rostock/DE
Uppsala/SE
Istanbul/TR
Milan/IT
Osaka/JP
Galway/IE
Abano Terme/IT
Bordeaux/FR
Munich/DE
Incheon/KR
Buenos Aires/AR
Leeds/UK
Oxford/UK
Coimbra/PT
Caen/FR
European Board of Interventional Radiology
18
Preliminary Faculty
Pellerin, O.
Peregrin, J.H. *
Pereira, P.L. *
Peynircioglu, B.
Pfammatter, T. *
Piroth, M.D.
Portugaller, R.H.
Pozzi-Mucelli, F.
Prevoo, W.
Qanadli, S.D.
Radeleff, B.A. *
Rand, T. *
Ratnam, L. *
Raupach, J.
Reekers, J.A. *
Reimer, P. *
Resch, T.A.
Riambau, V.
Richter, G.M. *
Rilling, W.S.
Rio Tinto, H.
Robinson, G.J.
Roebuck, D.J.
Roos, Y.B.W.E.M.
Rosales Sueiro, M.
Rousseau, H.
Ruffino, M.A.
Ryan, A.G.
Sabharwal, T. *
Sailer, A.M.H.
Salem, R.
Sapoval, M.R. *
Schaefer, J.P. *
Schoder, M. *
Schultze Kool, L.J. *
Schürmann, K. *
Shan, H.
Shoenfeld, R.
Sierre, S.
Sofocleous, C.T.
Solbiati, L.
Soulen, M.C.
Soulez, G.
Sousa, P.F. *
* EBIR Diploma holders
Paris/FR
Prague/CZ
Heilbronn/DE
Ankara/TR
Zurich/CH
Wuppertal/DE
Graz/AT
Trieste/IT
Amsterdam/NL
Lausanne/CH
Heidelberg/DE
Vienna/AT
London/UK
Hradec Králové/CZ
Amsterdam/NL
Karlsruhe/DE
Malmö/SE
Barcelona/ES
Stuttgart/DE
Milwaukee, WI/US
Lisbon/PT
Hull/UK
London/UK
Amsterdam/NL
Porto/PT
Toulouse/FR
Turin/IT
Waterford City/IE
London/UK
Maastricht/NL
Chicago, IL/US
Paris/FR
Kiel/DE
Vienna/AT
Nijmegen/NL
Dortmund/DE
Guangzhou/CN
West Orange, NJ/US
Buenos Aires/AR
New York, NY/US
Busto Arsizio/IT
Philadelphia, PA/US
Montreal/CA
Porto/PT
Spies, J.B.
Stracke, C.P.
Stroszczynski, C.
Szczerbo-Trojanowska, M.
Tacke, J. *
Taieb, J.
Tan, B.S.
Tapping, C.
Teng, G.-J.
Tesdal, I.K. *
Trerotola, S.O.
Trimarchi, S.
Tsetis, D.K. *
Tsitskari, M.
Tsoumakidou, G.
Turk, A.S.
Turmel-Rodrigues, L. *
Uberoi, R. *
Urbano, J. *
Válek, V. *
Valenti, D.A.
van Delden, O.M. *
van den Berg, J.C.
van Lienden, K.P.
van Overhagen, H. *
van Strijen, M.J.L.
Vano, E.
Veith, F.J.
Verhoeven, E.
Vermassen, F.E.
Vernhet-Kovacsik, H.
Vidal, V.
Vilares Morgado, P.
Vilgrain, V.
Vorwerk, D. *
Vos, J.A.
Waldenberger, P. *
Warren, P.
Watkinson, A.F. *
Weiss, C.R.
West, D.J. *
Wilhelm, K.E. *
Wohlgemuth, W.A.
Wolf, F. *
Washington, DC/US
Essen/DE
Regensburg/DE
Lublin/PL
Passau/DE
Paris/FR
Singapore/SG
Oxford/UK
Nanjing/CN
Friedrichshafen/DE
Philadelphia, PA/US
San Donato Milanese/IT
Iraklion/GR
Athens/GR
Strasbourg/FR
Charleston, SC/US
Tours/FR
Oxford/UK
Madrid/ES
Brno/CZ
Montreal/CA
Amsterdam/NL
Lugano/CH
Amsterdam/NL
The Hague/NL
Nieuwegein/NL
Madrid/ES
New York, NY/US
Nuremberg/DE
Ghent/BE
Montpellier/FR
Marseille/FR
Porto/PT
Clichy/FR
Ingolstadt/DE
Nieuwegein/NL
Salzburg/AT
Columbus, OH/US
Exeter/UK
Baltimore, MD/US
Stoke-on-Trent/UK
Bonn/DE
Regensburg/DE
Vienna/AT
C RSE
19
Lisbon 2015
ESIR 2015
Courses
European School of Interventional Radiology
Fundamental Courses
Recent structural changes have proved immensely popular, so fundamental courses
will continue to cater to doctors who are beginning their IR career, or would like
to refresh or broaden their existing portfolios. Lectures will cover both theory and
clinical application, with ample time devoted to hands-on learning. The course content
is specifically tailored to reflect the priorities and goals outlined in the European
Curriculum and Syllabus for Interventional Radiology.
TIPS and Portal Venous Disease
Rome (IT), June 5-6, 2015 | Sapienza University of Rome
Arterial Problems in Obstetrics and Gynaecology
Flensburg (DE), June 12-13, 2015 | DIAKO Flensburg
DVT & Pulmonary Embolus
Dublin (IE), November 27-28, 2015 | Royal College of Surgeons in Ireland
Expert Courses
Expert courses are specially designed for experienced practitioners already familiar
with the topic’s theoretical aspects and the relevant literature. Distinguished faculty
members guide these sessions, but considerable emphasis is also placed on facilitating
exchanges amongst participants. Sessions include a variety of practical exercises,
while lecture times are limited and primarily focus on outlining specific
"Tips & Tricks".
Critical Limb Ischaemia – Diagnosis, Treatment and Parameters for Success
Amsterdam (NL), October 16-17, 2015 | Academic Medical Center
Prostate Embolisation
Milan (IT), October 29-30, 2015 | AIMS Academy
Effective Hepatocellular Carcinoma (HCC) Treatments – Advanced Local
Therapies
Lausanne (CH), November 13-14, 2015 | CHUV Lausanne
The Future of Image-Guided Tumour Ablation – Targeting Techniques and
High-End Clinical Strategies
Innsbruck (AT), December 11-12, 2015 | LKH Innsbruck
For more information, please visit www.cirse.org/esir2015
C RSE
foundation
20
CIRSE Session Types
Amazing Interventions
The aim of this session is to present examples of unusual
and difficult interventional procedures. Acclaimed experts in interventional radiology will present brief cases of their most unusual and challenging procedures. The emphasis of the session
will be to highlight innovative ways that interventional radiologists can solve difficult problems and get out of trouble. It is envisaged that the session will be both educational and entertaining.
Featured Papers:
In order to achieve a more interactive format to the Free Paper
Sessions, one paper per session will be highlighted. More time
will be dedicated to this featured paper by means of further
questions prepared prior to the meeting by the moderator.
This will ensure a more structured and thorough discussion of
the topic.
Fundamental Courses
Aortic Round Tables
The Aortic Round Tables feature a new session format that
facilitates addressing important aspects of aortic interventions
in an informal setting. Key opinion leaders will outline their
views regarding select “hot topics”, and then engage in lively
discussions thereof with both their fellow speakers and the
audience.
Fundamental Courses cover a specific area of interventional radiology, focusing on basic principles and illustrating the
procedure in a step-by-step fashion. They are designed for
radiologists in training and new consultants, as well as for
experienced consultants who require a refresher course on
the subject. There will be plenty of time for questions and
discussion. Each session will last one hour.
"CIRSE meets …" Session
Hands-on Workshops
The “CIRSE meets …“ programme proved to be an important
platform for establishing and strengthening the relations
between CIRSE and its distinguished Group Members – the
national societies in the field of interventional radiology.
For the detailed programme, please refer to page 35.
The participants of Hands-on Workshops can follow live demonstrations of interventional techniques and practice certain procedures under the guidance of a technician and/or instructor.
For the detailed programme, please refer to pages 37-39.
Hot Topic Symposia
Evidence Fora
Evidence Fora are a type of Special Session focusing on
the outcomes of major trials investigating devices or techniques
for conditions commonly treated by interventional radiologists. Each forum will consist of several short talks presented
by leaders in the field. Each speaker will present the evidence
for and against the use of a specific device or technique for the
treatment of the disease under evaluation. At the end of the
session, the moderator will summarise the evidence presented
and provide conclusions regarding the best method of
treatment based on the current evidence.
Film Interpretation Quiz
The Film Interpretation Quiz is one of CIRSE’s most popular
sessions and will be run as a “last man standing” quiz. The Quiz
Master will present the audience with two possible answers to
each case – those choosing incorrectly will be eliminated and
must sit down, while those who get the answer right will continue to the next case. The last few contestants left standing
will be invited onstage for a head-to-head finale.
The Hot Topic Symposia aim to address important IR topics that
are current and controversial in the setting of a plenary session.
Invited speakers will give brief lectures on important aspects of
the subject under discussion. A major feature of these sessions
will be a round table discussion involving the speakers and the
audience.
Interactive Case Sessions
CIRSE‘s Interactive Case Sessions are divided into several topics.
After experts have shown individual cases, the audience is
asked for its opinion on treatment. These interactive sessions
provide an excellent learning experience on how to approach and
work up difficult cases and deal with complications that may arise.
Lecture Sessions
Lecture Sessions feature targeted presentations addressing
diverse issues in minimally invasive aortic aneurysm repair.
Each session concludes with a lively debate of the particular
topic’s most controversial aspects.
Free Paper Sessions
Morbidity & Mortality Conference
Researchers will present original papers on new and original
aspects of cardiovascular and interventional radiology. Selected papers will be gathered into sessions, each dealing with a
homogenous topic. There will be time for discussion between
researchers and attendees after each presentation.
The Morbidity and Mortality Conference will analyse interventional radiology cases which led to complications and/or deaths that
could have been avoided. This session provides a valuable learning
experience for everyone involved in interventional radiology.
The session will be dedicated to vascular and non-vascular cases.
Lisbon 2015
Special Sessions
With modern medical practice increasingly specialised, it is
becoming ever more important for physicians from different
specialties to share their respective perspectives and together
devise the best treatment plans for individual patients.
Drawing on the collaborative tradition of tumour boards, the
Multidisciplinary Expert Boards feature stimulating interdisciplinary exchanges on commonly-encountered challenges
in the oncological and vascular fields.
Special Sessions are designed to impart the latest knowledge on topics of interest to interventional specialists. These
sessions are the backbone of the CIRSE meeting and are
specifically chosen by the programme planning committee
because of their importance in daily practice.
Satellite Symposia
Satellite Symposia are organised by companies and take place
at lunchtime as well as in the morning and in the evening
in order to avoid time conflicts with the main scientific
programme. During these sessions cutting-edge information
on interventional equipment and techniques is provided.
The Satellite Symposia programme will be published in the
main programme.
The X-Session
This session is a one-time feature held in honour of CIRSE’s
30th anniversary. Six past CIRSE presidents will share anecdotes
about seminal moments in their career that shaped their
approach to interventional radiology. These may involve an
unusual encounter, a particularly intriguing case, or an unexpected development or outcome. Each speaker will conclude
their presentation by outlining their own personal advice for
the audience.
Workshops
During Workshops you will have the chance to learn from your
colleagues’ expertise in an informal, interactive manner. Workshops will entail individual cases and discussion points with
regard to the particular interventional topic. Attendees can
contribute their opinions and ask questions in small groups.
How to navigate the
scientific programme
INTERVENTIONAL ONCOLOGY
As an exciting and dynamic field of IR, interventional oncology
forms an integral part of the CIRSE programme. A new feature
this year, the Multidisciplinary Expert Board, will discuss the
treatment of hepatocellular carcinoma, showing how experts
perform a critical appraisal of clinical, laboratory and imaging
data to develop a personalised, multidisciplinary treatment
strategy.
HCC will be further explored in a number of Special Sessions,
including one devoted to liver transplantation. Malignancies of
other organs, such as the kidney, lungs and pancreas, will also
be explored, as will palliation strategies. Alongside a number
of case-based discussion workshops, participants can partake
of active learning at the Interactive Case Session on difficult
and unusual tumour ablations.
The programme is designed to facilitate itinerary planning
allowing delegates to follow one of these themes with little
or no overlap. In this booklet you will find colour codes for
each of the six main themes. Those codes can be found
throughout the whole programme (programme overview,
main theme description, programme in chronological order).
This way you will easily recognise your topics of interest.
IR MANAGEMENT
Clinical engagement is an important feature of modern IR,
and patient safety and quality assurance are essential considerations for any clinician. The IR Management track at CIRSE
2015 will help participants to improve their understanding of
these issues, and to enhance their own practice.
Radiation safety will be a key topic this year, with a special
Controversies debate examining the pros and cons of various
approaches, and a workshop dedicated to dose optimisation
and monitoring. Quality assurance will also be addressed, and
those interested learning more about the business side of IR
will benefit from Credibility and value for money: the keys to
success. To encourage continuing uptake of the EBIR certification, a preparatory workshop will be offered.
21
22
NEUROINTERVENTIONS
NONVASCULAR INTERVENTIONS
Since 2010, a dedicated Neurointerventions track has been
updating interventionists on the endovascular treatment of
haemorrhagic and ischaemic stroke. Ongoing developments
in imaging and devices are expanding the potential role of
interventional radiologists in diagnosis and treatment, and this
track offers an excellent opportunity to get abreast of these.
Of particular interest is the session How to improve acute stroke
management: new horizons, where participants can learn about
future techniques and devices in stroke treatment. The programme also features an Interactive Case Session, which will
allow the audience to get actively involved in the discussion of
both simple and challenging cases, as well as an introductory
Fundamental Course and several workshops.
TRANSCATHETER EMBOLISATION
Non-vascular interventions play an important role in providing state-of-the-art patient care across a range of pathologies.
Interventions in both benign and malignant biliary disease play
a special role in the daily work of an interventional radiologist.
Percutaneous procedures in the bile duct range from basic,
commonly occurring ones to exceptionally complex and challenging ones, and a variety of sessions at CIRSE 2015 will address this broad clinical spectrum.
Another core theme in this year’s non-vascular track will be
bone tumours, with various Special Sessions and Workshops
addressing their treatment. A Fundamental Course will introduce novices to image-guided biopsy and drainage procedures, and various case-based discussions on the treatment
of pancreatitis and challenging urinary tract interventions will
also be featured.
VASCULAR INTERVENTIONS
Embolisation is a versatile therapy, and one which forms an
essential part of every IR’s repertoire. The transcatheter embolisation track of the CIRSE 2015 programme will, as always,
endeavour to span a wide range of applications, from gastrointestinal bleeding to vascular malformations, and even new
applications such as bariatric embolisation. Due to growing
interest, a number of workshops and fundamental courses will
be offered in the genitourinary field, including treatment of
symptomatic fibroids, benign prostatic hyperplasia and varicoceles.
Trauma interventions will be a key focus, with an interactive
case session taking participants through the clinical management of traumatic bleeding. The use of microcatheters, including suitable embolic agents and complex techniques, will also
be discussed.
The vascular interventions track will once again be the cornerstone of the 2015 congress. Widely employed interventions
such as haemodialysis access management, carotid stenting
and peripheral revascularisation will be addressed in a wide
range of session types, while the important field of aortic interventions will get its own parallel symposium, open to all CIRSE
2015 delegates, which will be delivered by a multidisciplinary
faculty.
This year’s special emphasis on venous interventions is in direct response to the increasing patient demand for minimally
invasive venous disease treatment, and a dedicated Venous
Forum series will be offered, alongside a number of case-based
discussions, hands-on workshops and "controversies" sessions
dealing with the topic.
C RSE
Lisbon, Portugal
September 26-30
CIRSE 2015
24-25
26-27
28
29
30-31
32
33
34
35
37-39
40-43
44-47
48-51
52-55
56
IDEAS
Venous Interventions
Controversies in Arterial Intervention
Evidence Fora
Hot Topic Symposium – Paediatric IR
The X-Session
CIRSE meets China
Hands-on Workshops
Saturday, September 26
Sunday, September 27
Monday, September 28
Tuesday, September 29
Wednesday, September 30
IDEAS
2
0
1
I n t e r d i s c i p li n a r y
Endovascular
Aortic Symposium
5
AORTIC INTERVENTIONS
overview of the current status of a particular clinical issue,
before opening the floor to a panel discussion.
The growing uptake of endovascular treatment for various
aortic pathologies, and the continuing evolution of devices to facilitate it have led to an increased demand for
data and discussion. And not just among interventional
radiologists – vascular surgeons and cardiologists are
actively seeking the least invasive way of treating their
patients, and endovascular options offer much promise.
But there is much to be done before definitive treatment
strategies are agreed upon.
Treatment of both thoracic and abdominal pathologies
are improving year by year, thanks largely to technological
advances. However, there remains a paucity of data to
indicate which techniques and devices to use for which
manifestations. This session will address key concerns,
starting with an examination of thoracic aortic trauma by
Hervé Rousseau (Toulouse/FR).
To this end, CIRSE is hosting a new multidisciplinary endovascular symposium, IDEAS, which will offer a forum to
all interested medical practitioners to explore and discuss
the current status of various aortic inter ventions, and
evaluate where the field is headed. Those attending CIRSE
2015 will have unrestricted access to this exciting new
scientific stream.
Hot Topic Symposium
The Hot Topic Symposia are an ideal platform for examining controversial treatment issues, and this year’s symposium on aortic interventions will be no different. Four
speakers will each give a detailed
Acute type B dissections continue to raise challenges
for the physician. While it is largely accepted that medical
treatment can suffice for many uncomplicated type B
acute aortic dissection patients, complicated presentations (approx. 30% of presentations) entail complex
decision-making. To make things more difficult still, no
uniform criteria exist to differentiate between the two,
and presenter Richard Gibbs (London/UK) will attempt to
bring clarity to this issue.
A key aspect of complicated acute type B dissections is
malperfusion syndrome. Clinical signs, such as paresis or
pain, can indicate malperfusion, but laboratory markers
provide a more sensitive method of detection. The
mechanisms and management of malperfusion syndrome
will be discussed by Jean-Paul Beregi (Nîmes/FR).
Finally, abdominal pathologies will be explored by
Frank Veith (New York, NY/US), who will address the
management of ruptured abdominal aortic aneurysms,
and which patients are suitable for endovascular repair.
Jean-Paul Beregi
Richard G.J. Gibbs
HTS 1302 Aortic intervention – quo vadis?
Introduction by the moderators:
A.-M. Belli (London/UK), F. Fanelli (Rome/IT)
1302.1 Thoracic aortic trauma
H. Rousseau (Toulouse/FR)
1302.2 Complicated acute type B dissection
R.G.J. Gibbs (London/UK)
1302.3 Malperfusion syndromes in acute aortic dissection
J.-P. Beregi (Nîmes/FR)
1302.4 Ruptured abdominal aortic aneurysm
F.J. Veith (New York, NY/US)
Hervé Rousseau
Frank J. Veith
C RSE
IDEAS HOT TOPIC SY
YMPOSIA
Aortic Round Tables
To allow for open discussion of aortic therapies, the IDEAS
2015 programme will feature Aortic Round Table sessions,
at which key opinion leaders from both interventional
radiology and vascular surgery will outline their views
regarding select "hot topics", before engaging in lively
discussions with both their fellow speakers and the
audience.
Abdominal aorta
The first of these innovative sessions will address clinical
issues pertaining to the abdominal aorta. Although EVAR
is now widely used for treating AAA, there remains a lack
of clarity on its value in all patients, and the indications
and limitations of EVAR need further discussion.
An ongoing issue with EVAR is long-term durability.
Endoleak and device migration remain a challenge, and
ongoing surveillance of patients is a must.
The anatomy of the proximal neck is a major deciding
factor in selection of both technique and device, and the
session will attempt to address how best to overcome
atypical presentations.
Also under discussion will be endovascular repair of
ruptured abdominal aortic aneurysms. Recent randomised
controlled trials, such as AJAX and IMPROVE, have brought
some clarity, but there is still much debate about which
patients are suitable for EVAR (there are set anatomical contraindications, but beyond that, are all patients
suitable?) and when to convert to open surgery.
The management of aorto-iliac aneurysms is likewise an
area of much debate, and our expert panel will attempt to
determine if and when internal iliac artery preservation is
necessary, and which patients benefit from aorto-uni-iliac
or fenestrated EVAR over standard EVAR.
ART 1410 Abdominal aorta
Thoracic aorta
The second Aortic Round Table in the inaugural IDEAS
programme deals with treatment options in the thoracic
aorta. Aortic dissection is 2-3 times more common than
rupture of AAA, and some categories of type B dissections
(those in the descending aorta, distal to the left subclavian
artery) may benefit from endovascular treatment.
The session will open with a discussion of arch aneurysm
management. Increasingly, endovascular stent grafts
are being employed to treat these complicated aneurysm types, but the curvature, increased pressure and
branching arteries of the arch raise specific challenges
for endovascular therapies. Can new device innovations,
such as fenestrated and branched endografts, overcome
these?
Treating this complex zone is not without risk, and
practitioners should be aware of the possibility of spinal
cord damage, stroke, and other complications, and how
these can be best avoided or managed.
Similarly, endovascular treatment of chronic dissection
in the descending aorta can give rise to a number of
complications. Although newer percutaneous devices
entail a smaller entry wound than traditional cut-downs,
large introducer systems mean that bleeding complications are an inherent risk in current practice. Practitioners
must also beware of converting type B to type A dissections, uncontrolled tearing of the intimal flap, and most
especially, aortic rupture.
Finally, endografting for acute aortic dissection will be
addressed, and the results of the current studies, ADSORB
and INSTEAD and their implications for patient selection
will be discussed.
Monday, September 28, 14:30-15:30
ART 2103 Thoracic aorta
1410.1 Customised follow-up in EVAR
tba
1410.2 Technique selection in the devious
proximal neck
B.T. Katzen (Miami, FL/US)
1410.3 Management of RAAA
J.C. Parodi (Buenos Aires/AR)
1410.4 Management of aorto-iliac aneurysms
V. Riambau (Barcelona/ES)
2103.1 Arch aneurysm management
M.D. Dake (Stanford, CA/US)
2103.2 Paraplegia prevention and management
in TAAA branched grafting
S. Haulon (Lille/FR)
2103.3 Management of complications of
chronic dissection
C. Nienaber (Rostock/DE)
2103.4 Acute type B dissection
S. Trimarchi (San Donato Milanese/IT)
...the full programme is available at www.aorticideas.org
IN THE SPOTLIGHT
VENOUS INTERVENTIONS
A Focus on Venous Interventions
In recent years, interventional radiology has seen a sharp
uptake in venous procedures, and this year’s scientific
programme reflects that development. Venous diseases
are a major global healthcare problem, affecting a vast
number of people and causing grievous social and
economic effects. Today’s sedentary lifestyle, lack of
exercise, smoking and obesity contribute considerably to
the emergence of venous conditions.
For years, interventional radiology has been at the
forefront of tackling these diverse venous issues, which
range from varicose veins, deep vein thrombosis (DVT)
and pulmonary embolism (PE), to portal hypertension
and chronic venous insufficiency (CVI).
sites can be successfully restored. The possibility of
pre-emptively dilating these stenoses will be investigated
by experts in the controversy session.
Pulmonary embolism is commonly treated with anticoagulants, but where anticoagulation is contra-indicated,
IR offers an alternative treatment option using IVC filters.
Filters can be placed permanently or can be retrieved,
with high retrieval success rates of 98%. In this special
controversy session, experts will debate whether the use
of permanent filters is still feasible or whether the future
lies exclusively in retrievable filters.
Due to the rarity of Paget Schroetter syndrome, there is
no consensus regarding its optimal treatment. Currently,
many believe that surgery is necessary, but this debate will
examine the potential of minimally invasive alternatives.
Controversies in IR
Fundamental Course
The popular Controversy Sessions will this year dissect
some hotly debated issues in venous disease treatment,
including stenosis in dialysis access, filters and Paget
Schroetter syndrome.
New this year is the venous Fundamental Course, which
will examine the principles of haemodialysis access
treatment. Maintaining a functioning haemodialysis
access is a challenging task requiring vigilant surveillance
in order to prevent complications, such as thrombosed
grafts, central vein occlusions, or fistulas which fail to
mature. The course will consider the evidence and indications for failing dialysis access management and
address the possible complications.
The management of dialysis access is an important part
of IR’s venous repertoire. On average the durability of a
haemodialysis access is limited to three years, which is
often followed by the development of a stenosis. Thanks
to catheter-based interventions, more than 80% of access
SS 301 Controversies in venous disease treatment
301.1
301.2
301.3
301.4
301.5
301.6
Pre-emptive dilation of stenoses in
dialysis access
Pro: B.S. Tan (Singapore/SG)
Con: R. Shoenfeld (West Orange, NJ/US)
Permanent filters are obsolete
Pro: O. Pellerin (Paris/FR)
Con: S.D. Qanadli (Lausanne/CH)
Surgery for Paget Schroetter syndrome
is mandatory
Pro: S. Black (London/UK)
Con: G.J. O’Sullivan (Galway/IE)
FC 201 Basic principles of haemodialysis access
maintenance
201.1 Current evidence and indications for failing
dialysis access management
L. Turmel-Rodrigues (Tours/FR)
201.2 Thrombosed dialysis access
F.G. Irani (Singapore/SG)
201.3 Treatment of central vein occlusions
A.M. Madureira (Porto/PT)
201.4 Non-maturated dialysis access
S.O. Trerotola (Philadelphia, PA/US)
C RSE
Venous Fora
This year’s strong emphasis on venous interventions also
encompasses a brand new series of sessions, the Venous
Fora, in which experts will shed light on a variety of
topics related to the management of venous disorders.
One of the four dedicated fora will delve deeper into the
topic of varicose veins. These twisted, enlarged veins are
not merely a cosmetic concern but can be a troublesome
burden affecting a patient’s quality of life. Specialists
will approach the topic from different angles, covering
diverse techniques and patient selection.
The evidence for various DVT treatment options will be
discussed in another targeted venous forum. Currently,
roughly 200,000 new cases of DVT are diagnosed each
year in the USA, affecting both the young and old, the
healthy and unwell, with devastating results: DVT is the
third biggest cause of cardiovascular mortality after
stroke and heart attack.
SS 101 Venous Forum I: Varicose veins
101.1 Patient selection, clinical and imaging
assessment
J.A. Kaufman (Portland, OR/US)
101.2 Thermal ablation
L. Oguzkurt (Istanbul/TR)
101.3 Non-thermal ablation
M. Åkesson (Malmö/SE)
101.4 Ancillary therapies: mini-phlebectomy
and foam sclerotherapy
D.J. West (Stoke-on-Trent/UK)
SS 904 Venous Forum II: Deep vein thrombosis
904.1 Trials update and current evidence
S. Kee (Los Angeles, CA/US)
904.2 Patient selection and treatment:
upper limb DVT
V. Bérczi (Budapest/HU)
904.3 Patient selection and treatment:
lower limb DVT
J. Kettenbach (St. Pölten/AT)
904.4 Chronic iliac vein and caval occlusion
R. de Graaf (Maastricht/NL)
DVT can lead to life-threatening pulmonary embolism,
which, if it occurs acutely, requires immediate medical
attention. Non-treatment results in a mortality rate of
approximately 30%. The treatment path commonly
starts with anticoagulation, however, if contraindi-cations
arise, interventional measures are employed through IVC
placement. Assessing and selecting patients, as well as
sufficient evidence, are still unclear and debatable topics
and will be the focus of the third forum.
Interventional techniques have proved beneficial in
the alleviation of problems associated with portal
hypertension, such as ascites and variceal bleeding.
Transjugular intrahepatic portosystemic shunt (TIPS) and
balloon-occluded retrograde transvenous obliteration
(BRTO) will be put under the microscope in a dedicated
venous forum.
SS 1702 Venous Forum III: Pulmonary embolism and
IVC filters
1702.1 PE: patient assessment and selection
for treatment
M.K. Glynos (Athens/GR)
1702.2 Treatment options for pulmonary embolism
P.M. Paprottka (Munich/DE)
1702.3 Current evidence on IVC filter placement
M.-F. Giroux (Montreal/CA)
1702.4 Challenging placements and retrievals
C.A. Binkert (Winterthur/CH)
Wednesday, September 30, 08:30-09:30
SS 3201 Venous Forum IV: Portal hypertension
3201.1 TIPS for refractory ascites and variceal bleeding
É. Coimbra (Lisbon/PT)
3201.2 Percutaneous treatment options in portal
vein thrombosis
A. Krajina (Hradec Králové/CZ)
3201.3 Percutaneous management of Budd-Chiari
syndrome
I.K. Tesdal (Friedrichshafen/DE)
3201.4 BRTO – why, when and how?
K. Kichikawa (Nara/JP)
28
IN THE SPOTLIGHT
MULTIDISCIPLINARY EXPERT BOARDS
With modern medical practice becoming increasingly
specialised, it is becoming ever more important for
physicians from different specialties to share their
perspectives and together devise the best treatment
plans for individual patients. Drawing on the collaborative tradition of tumour boards, the Multidisciplinary
Expert Boards feature stimulating interdisciplinary
exchanges on commonly encountered challenges in the
oncological and vascular fields.
Complex real-world cases, often with the possibility of
different treatment options, will be discussed. The cases
presented will include the clinical history, performance
status, pertinent imaging findings and a plan for further
treatment.
The first session will focus on the most common type of
liver cancer – hepatocellular carcinoma. Due largely to
the increasing prevalence of chronic liver disease, HCC
has become a growing problem worldwide; despite
considerable progress in detection, diagnosis and treatment, it is the third leading cause of cancer death.
In the second expert board, IRs and a vascular surgeon
will investigate the topic of aortic disease – an area
that is gaining momentum in IR and that represents a
special focus of this year’s programme. IR has entered
the field with EVAR and TEVAR, procedures that hold
much promise but also require further refinement and
supporting evidence.
MEB 305 Tumour: hepatocellular carcinoma
Co-ordinator: R. Lencioni (Pisa/IT)
Panellists:
Y. Arai (Tokyo/JP); interventional radiologist
M. Bezzi (Rome/IT); interventional radiologist
J. Bruix (Barcelona/ES); oncologist
U. Cillo (Padua/IT); surgeon
T. de Baère (Villejuif/FR); interventional radiologist
MEB 2210 Aortic disease
Co-ordinators: K.A. Hausegger (Klagenfurt/AT),
C. Liapis (Athens/GR)
Panellists:
M.D. Dake (Stanford, CA/US); interventional radiologist
M. Jenkins (London/UK); vascular surgeon
J.C. Parodi (Buenos Aires/AR); vascular surgeon
The last session will centre on peripheral arterial diseases
(PAD), with an emphasis on carotid stenosis. The buildup of plaque creates stenosis in the carotid artery, and
its often asymptomatic nature makes it a particularly
alarming healthcare problem. Frequently, symptoms are
only discovered with the onset of a transient ischaemic
attack (TIA), which further heightens the risk of stroke.
Carotid artery stenosis can be treated with medications,
carotid endarterectomy (CEA) or minimally invasive
approaches, which include carotid angioplasty and
stenting.
MEB 2705 PAD: carotid stenosis (conservative/
medical, CEA, CAS)
Co-ordinator: D. Vorwerk (Ingolstadt/DE)
Panellists: tba
C RSE
29
Lisbon 2015
CONTROVERSIES IN ARTERIAL INTERVENTION
As always, this year’s Controversy Sessions provide a
forum for spirited discussions on controversial issues that
divide the IR community. Featuring three sets of cuttingedge debates each, these sessions will push practitioners
to re-think their presumptions by confronting them
with the best arguments both for and against particular
aspects of modern IR practice. One such session will
address controversies in arterial intervention.
Initially embraced as a game-changer in treating drugresistant hypertension, renal denervation was widely
dismissed as ineffective after the SYMPLICITY HTN-3 trial,
which included a sham-controlled arm, was called off for
failing to demonstrate statistically significant benefits.
However, others maintain that such strong conclusions
may not be warranted, and that further studies may still
demonstrate that the procedure, if properly refined and
applied, can yield positive results.
The popliteal artery has often been described as a
hostile environment for stenting due to high levels of
biomechanical stress next to the knee joint, with critics
noting that stent fractures and consecutive restenosis
are of particular concern in this vessel. Others insist that
these problems have been overblown, emphasising
that more flexible stent variations entail lower risks
of fracture, and that fractures may not necessarily be
strongly correlated to patency.
When carotid artery stenting emerged as an alternative
treatment for carotid artery stenosis, many insisted that
endarterectomy, the surgical option, should remain the
first choice. Early analyses of the International Carotid
Stenting Study, which compared the two approaches,
appeared to support those who endorsed surgery. But
newly available analyses of long-term results, which
show that surgery entails a higher risk of procedural
myocardial infarction, cranial nerve palsy, and accesssite haematoma, and that strokes triggered by the
endovascular approach tend to be minor, may now shift
the balance towards CAS.
Join us to find which way the evidence is pointing for
modern arterial interventions!
SS 1004 Controversies in arterial intervention
Renal denervation is dead
1004.1 Pro: J.A. Reekers (Amsterdam/NL)
1004.2 Con: M.R. Sapoval (Paris/FR)
Popliteal stents are effective
1004.3 Pro: M. Cejna (Feldkirch/AT)
1004.4 Con: H. Kobeiter (Créteil/FR)
ICSS long-term data will lead to resurgence of CAS
1004.5 Pro: A.H. Mahnken (Marburg/DE)
1004.6 Con: B.T. Katzen (Miami, FL/US)
IN THE SPOTLIGHT
CIRSE CONSIDERS THE EVIDENCE
The Evidence Fora allow interventional radiologists to keep pace with the latest developments in the treatment of select conditions. Experts present the most up-to-date research on a particular treatment option,
using trials and evidence to support their case. This equips the audience with clear and rigorous information,
enabling them to judge what therapy is suitable for their patients.
Evidence Forum: Drug-eluting devices
Initially applied to coronary arteries, drug-eluting devices
are now also increasingly used in peripheral procedures.
While these have shown considerable promise, results
achieved in the various arterial beds have been mixed,
and solid evidence remains relatively sparse, precluding
broad conclusions.
The supra-aortic vessels present unique challenges. For
example, treating intracranial atherosclerotic disease,
a major cause of ischaemic stroke, remains difficult.
Endovascular treatment options are rapidly developing,
but remain risky, and recurring in-stent stenosis is of
particular concern. Drug-eluting stents have shown
promise in limiting such lesions, but stent stiffness
has also significantly impeded technical success rates.
Now newer, more flexible stents, which entail fewer
manoeuverability issues, are triggering renewed
optimism.
Durable results in the superficial femoral artery are
difficult to achieve, and the role of drug-eluting devices
remains a point of considerable discussion. Even
proponents shy away from blanket endorsements, with
drug-eluting balloons in cases involving highly-calcified
or longer lesions subject to considerable skepticism.
The value of drug-eluting stents has also been
questioned. However, proponents emphasise that
the use of paclitaxel promises to bring considerable
improvements.
Practitioners also disagree about drug-eluting devices in
below-the-knee interventions. With restenosis a major
issue, such stents clearly are of some value, but the
dearth of relevant clinic results is a problem, particularly
with respect to long lesions. Recent research does
suggest that paclitaxel-eluting balloons hold promise
and may, in select patients, significantly reduce restenosis
rate, but results are still preliminary.
Restenosis following angioplasty is a common problem
with dialysis access fistulas and grafts, and the myriad
attempts to address this issue have had limited success.
Critics of efforts focusing on drug-eluting balloons note
that the haemodynamic properties of access vessels likely
prevent DEBs from being truly effective in this context.
However, initial research results suggest that cautious
optimism may be warranted. Treating stenosed grafts
with drug-eluting stents has also shown some promise, but the lack of solid research results so far make it
difficult to quantify their potential.
The session will provide an overview of the emerging
evidence by way of expert presentations and a panel
discussion, followed by an opportunity for audience
members to pose questions.
SS 2602 Evidence Forum: Drug-eluting devices
2602.1 Drug-eluting devices in supra-aortic lesions
R. Gandini (Rome/IT)
2602.2 Drug-eluting devices in haemodialysis access
R.H. Portugaller (Graz/AT)
2602.3 Drug-eluting devices in SFA lesions
P. Krishnan (New York, NY/US)
2602.4 Drug-eluting devices in BTK lesions
N. Chalmers (Manchester/UK)
C RSE
Image courtesy of
Prof. Stefan Müller-Hülsbeck
Evidence Forum: Peripheral angioplasty
Peripheral artery disease can strike in many forms, and
each manifestation of the condition entails unique risks
and challenges. Depending on its severity, treatment
options generally include lifestyle changes, medication,
and surgical or endovascular revascularisation. Surgery
has traditionally been the treatment of choice, but
endovascular approaches have evolved rapidly,
producing good results even with extensive forms of
the disease. With surgical follow-up still an option when
percutaneous efforts fail, practitioners increasingly
maintain that endovascular intervention should trump
open reconstruction.
This is particularly true with respect to aorto-iliac
occlusive disease, which can present anywhere from the
distal aorta to the common femoral arteries, and involves
diverse lesion morphology. Results achieved with
minimally invasive approaches have been increasingly
accurate and successful even with particularly complex
cases. Though complications, especially involving the
access site, persist, perioperative morbidity remains a
bigger problem with surgery. Primary patency rates do
present a continuing problem, but reintervention can
improve results.
Treating femoropopliteal disease with percutaneous
techniques remains somewhat controversial, with longterm patency rates of particular concern. Choosing
between available endovascular options, which include
angioplasty and/or various forms of stent implantation,
has also proved difficult, and cutting-edge innovations, including drug-eluting technologies, add further
complexity.
Infra-popliteal disease still presents a considerable
challenge for both surgeons and interventional
radiologists. However, percutaneous approaches are
increasingly being hailed as the better option due to
lower mortality and morbidity rates, as well as costs.
Technological advances again are playing a vital role,
with endovascular techniques now including − and
combining − various options beyond PTA, including
cutting balloon angioplasty, stenting, cryotherapy, and
atherectomy devices.
Percutaneous approaches have also recently gained
ground in the treatment of visceral artery occlusive
disease, a rare condition that is difficult to diagnose.
These reportedly entail high technical and immediate
clinical success rates, and less morbidity and mortality.
While the need for reintervention remains relatively high,
combining angioplasty with stenting of the mesenteric
arteries may improve long-term patency.
This session will explore the latest developments
with respect to all of these diseases in the context of
addressing whether balloon angioplasty should be the
first treatment of choice.
SS 205 Evidence Forum: Peripheral angioplasty
205.1 Should balloon angioplasty be the first-line
treatment for aorto-iliac occlusive disease?
A.M.H. Sailer (Maastricht/NL)
treatment for femoropopliteal disease?
S. Müller-Hülsbeck (Flensburg/DE)
treatment for infra-popliteal disease?
T. Rand (Vienna/AT)
treatment for visceral artery occlusive disease?
J.V. Patel (Leeds/UK)
32
IN THE SPOTLIGHT
HOT TOPIC SYMPOSIUM  PAEDIATRIC IR
Paediatric interventional radiology often adopts
procedures developed for adult patients, but
exchanges between practitioners who work with
adult populations and their counterparts in paediatric care are not a one-way street. While treating
children and adolescents involves unique challenges,
priorities and solutions, it often also results in
insights from which even interventional radiologists
who never work with younger patients can benefit.
Thrombolysis is a treatment option for several conditions
that share a particular trait: they are relatively rare
in paediatric patients. Nonetheless, practitioners are
increasingly confronting children and adolescents
suffering from DVT, ischaemic strokes, or acute limb
ischaemia. The lack of relevant data and tailored treatment guidelines can be problematic, with practitioners often operating without the benefit of relevant
published experience.
Aneurysmal bone cysts usually develop in patients who
are under 20 years old. They have traditionally been
treated with surgery, but recurrence is an issue. Minimally
invasive options include sclerotherapy and selective
arterial embolisation. The latter is often performed as
a precursor to surgery to reduce bleeding, but is also
increasingly used independently of curettage.
Four experts will further examine these diverse topics,
then engage in a discussion guided by the moderator,
allowing audience members to broaden their horizons by
learning about the latest developments in the intriguing
world of paediatric IR.
Lymphatic malformations of the orbit are rare lesions
that often present during childhood. Though benign,
they can cause deformities, pain and, if left untreated,
can result in blindness. Treatment remains difficult,
prompting some practitioners to adopt a wait-and-see
approach before resorting to surgery or percutaneous
drainage and ablation. But this is often not an option for
physicians treating small children, who are at greater risk
of suffering visual loss.
First introduced in the 1990s, thoracic duct embolisation
has become an important treatment option for chylous
leaks. Accurately localising the site of the leak is a vital
first step. This is usually done via pedal lymphangiography, which can be particularly difficult in children.
Now intranodal lymphangiography, a simpler approach,
has emerged as a possible alternative, meaning the
procedure may soon be more regularly resorted to even
in paediatric care.
Alex M. Barnacle
Anne M. Cahill
Maxim Itkin
HTS 2902 Paediatric IR – expand your horizons
Introduction by the moderator:
D.J. Roebuck (London/UK)
2902.1 Aneurysmal bone cysts
P. Warren (Columbus, OH/US)
2902.2 Lymphatic malformations of the orbit
A.M. Barnacle (London/UK)
2902.3 Lymphatic intervention in children
M. Itkin (Philadelphia, PA/US)
2902.4 Thrombolysis in children and adolescents
A.M. Cahill (Philadelphia, PA/US)
C RSE
Patrick Warren
33
Lisbon 2015
Cye RSE
Be sure to join us for…
a rs
THE XSESSION
CIRSE 2015 marks the organisation’s 30th anniversary, and
our celebrations will include a one-off special event: the
X-Session.
This light-hearted event will see those who helped shape
the discipline give personal insights into what IR means
to them, and will be sure to inspire.
This will be presented by six former CIRSE presidents,
who will share anecdotes about seminal moments in
their career that shaped their approach to interventional
radiology, and reflect on how the field of IR has grown
and progressed since their early involvement.
Don’t miss this unique opportunity to celebrate our
community and our specialty – join us for the X-Session
in Lisbon!
XS 2101 The X-Session
Speakers: A. Adam (London/UK), J. Lammer (Vienna/AT),
M.J. Lee (Dublin/IE), J.H. Peregrin (Prague/CZ),
J.A. Reekers (Amsterdam/NL), D. Vorwerk (Ingolstadt/DE)
Andy Adam
Johannes Lammer
Michael J. Lee
Jan H. Peregrin
Jim A. Reekers
Dierk Vorwerk
34
Workshops for radiographers
Interventional radiology is very much a team effort.
Optimal patient care can only be delivered if the physician
and the other team members, such as radiographers, are
well trained and highly professional in what they do.
11:30-12:30
RWS 1104 EFRS Workshop
Optimising radiation protection in
interventional radiology: what can the
radiographer do?
A growing number of radiographers working in the field
of interventional radiology are attending the annual CIRSE
congress. In order to cater to this development, CIRSE
and the European Federation of Radiographer Societies
(EFRS) are organising two interactive workshops especially
designed for radiographers and nurses.
11:30-12:30
Management of pain during IR procedures
1904.1 A. England (Manchester/UK)
1904.2 S. Morse (Manchester/UK)
1104.1 S. Mc Fadden (Belfast/UK)
1104.2 R. Gould (Belfast/UK)
The number of paediatric interventional radiology (IR)
procedures being performed has increased rapidly in recent
years. Interventional procedures have been reported to
contribute to the highest doses of radiation to patients from
medical examinations. It is imperative that we strive to reduce
the radiation burden to our radiosensitive paediatric patients.
Previous work by this group has estimated DRL for IR and
identified a wide variation of imaging protocols currently
being used in the UK and Ireland. These variations in practice
are having a significant impact on the resultant radiation dose
to the patient. Experimental studies on anthropomorphic
phantoms investigated the different variations in practice
and results showed that radiation dose reductions of up
to 50% could be achieved with minimal impact on image
quality. Further studies on paediatric patients in the clinical
environment are ongoing and preliminary results have
revealed similar findings. In addition, this clinical study has
investigated the effect of different scatter removal techniques
on radiation dose and associated DNA damage by quantifying
γH2AX-foci as a biomarker of radiation-induced effect. Again
preliminary results have identified that mean γH2AX-foci
can be significantly greater for different protocols which are
commonly used in IR. Simple modifications to technique can
be easily implemented by the radiographer. This will ensure
the radiation dose to paediatric patients is kept ALARA without
affecting image quality or diagnostic efficacy.
Learning objectives:
After active participation in this workshop, attendants will have
gained knowledge and understanding of:
• current research into radiographic protocols used in the
UK and Ireland for paediatric interventional radiology
• the impact of different protocols on radiation dose
• results of experimental studies investigating the different
protocols and their effect on image quality and dose
• results of radiation measurements during paediatric
interventional radiology and recommended DRLs
• the need for standardised protocols and radiation protection
measures
Research suggests that pain during and following interventional radiological (IR) procedures can be common and
its nature can vary considerably. Methods are available to
manage procedure-related pain; however, these can vary
and may have some dependence on the type of procedure,
assessment methods, pain management strategies available
and practitioner experience. Following completion of the
procedure, many patients will undertake recovery either at
home or within a hospital setting remote from the IR department. Patients who have reported pain often talk of delays
in receiving analgesia and that, when administered, it does
not always obtain the desired effect. Within other health
care disciplines, pain management is often a more intrinsic
part of the patient’s care pathway and often there is a clearer
focus on pre-emptive pain management. The purpose of this
presentation is to improve awareness amongst radiographers
as to the issue of pain management following IR procedures.
In doing so, the anticipated benefits will be improvements
in the patient experience; a faster, safer and more successful
IR procedure which could be delivered using a lower radiation
dose.
Learning objectives:
After participating in this workshop, attendees will be familiar
with:
• the methods for assessing pain during IR procedures
• patterns and predictive factors for pain during common
IR procedures
• the options for managing intra-procedural and
post-procedural pain, including a review of a series of cases
• the role of different professions in IR pain management
(radiologist, radiographer and nurse)
• future horizons for pain management within IR
A series of two workshops organised in co-operation with the
Lisbon 2015
CIRSE meets...
CIRSE meets...
China
Interventional radiology (IR) was introduced to China during
the 1980s in conjunction with China’s policy of economic
reform and opening up. IR was immediately accepted and
welcomed by most radiologists after its introduction. The
first national interventional radiology meeting was held in
1986 in Weifang City, Shangdong Province, and more than
100 radiologists, residents and graduate students participated.
This was a landmark event announcing the advent of IR in
China. Four years later, the Chinese Society of Interventional
Radiology (CSIR) was founded, and Dr. Lin was elected as
the first CSIR president at the first national CSIR meeting in
Hangzhou, Zhejiang Province, in 1990. The national meeting of
CSIR was held every 4 years in the early years, and then every
2 years, and will become annual meeting from 2015 onwards.
A total of eleven national CSIR meetings have been held. The
most recent CSIR biennial meeting was held in Changsha in
2014, with more than 3,000 IRs participating.
10:00-11:00
CM 2605 CIRSE meets China
Moderators: A.-M. Belli (London/UK),
H. Shan (Guangzhou/CN)
2605.1 Percutaneous transhepatic portosystemic shunt
2605.2 Stent loaded with 125I seeds in malignancies –
from bench to bedside
G.-J. Teng (Nanjing/CN)
2605.3 Hybrid intervention for complex cerebrovascular
disease
W.-J. Jiang (Beijing/CN)
Currently, there are approximately 5,000 full-time
interventional radiologists across the country, meaning that
CSIR has become the third largest IR society in the world, after
SIR and CIRSE. Most non-coronary IR procedures are performed
by radiologists, including various vascular and non-vascular
interventions, neurointerventions, etc. However, turf battles
have become intense since the 1990s, especially in the field of
vascular interventions and neurointerventions. Nevertheless,
we have not only survived, but also won the battles in many
hospitals. One of major reasons we manage to hold our ground
is that CSIR has been a strong advocate for interventional
radiology to be a more clinical specialty. Currently, over 70%
of IR departments in China have their own dedicated inpatient
wards. Some of them have become a hybrid department of
interventional radiology with other specialties, such as vascular
surgery.
Many IR pioneers have contributed to the growth of CSIR,
including overseas interventional radiologists, who made
important contributions to the practice of IR in China,
especially during the early years. To commend such great
contributions, the awards of CSIR Lifetime Achievement and
CSIR Honorable Member have been established, respectively.
So far, twelve Chinese IR pioneers and eight foreign
interventional radiologists have been awarded.
Hong Shan
President, Chinese Society of Interventional Radiology (CSIR)
The CIRSE meets… programme has proved to be an important
platform for establishing and strengthening the relations
between CIRSE and its distinguished Group Members – the
national societies in the field of interventional radiology.
Experts from various regions around the world have provided
interesting insights into the current status of interventional
radiology as well as the state of specific procedures and
conditions in their home countries.
35
36
Session Types
Certify your Expertise
in Interventional Radiology
Register now
for the next EBIR examinations:
LISBON, September 25-26, 2015
VIENNA, March 2-3, 2016
Limited places available for non-European candidates!
Don’t miss your chance!
For application deadlines and detailed information,
please visit our website at www.cirse.org/ebir
c/o CIRSE
Neutorgasse 9, 1010 Vienna, Austria
[email protected]
www.cirse.org/ebir
C RSE
C RSE
Hands-on Workshops
Lisbon 2015
37
Hands-on Workshops
A closer look at closure devices
Co-ordinators: J.P. Schaefer (Kiel/DE), R. Uberoi (Oxford/UK)
Embolisation: materials and tools
Co-ordinators: A. Martínez de la Cuesta (Pamplona/ES),
Vascular closure devices (VCDs) are commonly used for the
management of arterial puncture sites after therapeutic
arterial interventions.
This series of hands-on workshops provides an overview
of current embolisation materials and techniques.
This hands-on workshop will introduce VCDs currently
available on the market with a brief introduction to closure
devices. The focus will be on the hands-on experience, with
the opportunity to deploy devices and discuss the pros and
cons of using closure devices in different settings with experts.
Furthermore, many tips and tricks for the proper use of closure
devices in daily practice will be shared during the hands-on
part. The course will be concluded with a dedicated tutorial of
the "pre-close" technique for closing large arterial punctures
for total percutaneous aortic repair.
Thanks to the opportunity to try currently available closure
devices first hand, the workshop should enable all participants
to understand their various principles and indications.
Learning Objectives
– To become familiar with the currently available vascular
closure devices for peripheral and aortic interventions
– To understand when and how to successfully use a vascular
closure device
– To know when not to use a vascular closure device and how
to avoid complications
– To gain experience with the "pre-close" technique required
for total percutaneous treatment of aortic aneurysms
CD-HoW 1
CD-HoW 2
08:30-10:00
In each workshop, a brief introduction is followed by
participants rotating between various table-top demonstrations. The workshops may be attended as a series or
individually. Participants will engage informally with instructors and try out various embolic materials on anatomical
and flow models. The emphasis of the sessions is a practical
hands-on approach. Participants can handle and/or deliver
mechanical, liquid or particulate embolic agents (depending
on the session). This course is intended for IRs with limited
embolisation experience or those wishing to refresh their
knowledge.
Learning Objectives
– To understand the basic principles of embolisation
– To become familiar with common embolic agents
– To be able to choose an appropriate embolic agent
– To know how to correctly prepare and deliver the chosen
agent
– To understand how to avoid non-target embolisation and
other complications
EMT-HoW 1 – Coils & plugs
08:30-10:00
EMT-HoW 2 – Coils & plugs
11:15-12:45
EMT-HoW 3 – Liquid agents
EMT-HoW 4 – Liquid agents
08:30-10:00
11:15-12:45
EMT-HoW 5 – Particulate agents
EMT-HoW 6 – Particulate agents
08:30-10:00
11:15-12:45
11:15-12:45
38
Hands-on Workshops
Principles to practice:
education and simulation skills training
Co-ordinators: D.O. Kessel (Leeds/UK),
J.C. van den Berg (Lugano/CH)
Tumour ablation: tips and tricks
Co-ordinators: L. Hechelhammer (St. Gallen/CH),
T.K. Helmberger (Munich/DE)
This popular series of workshops comprises a one-hour
round-table discussion with experts in the field, delivering
key knowledge and practical tips, followed by one hour of
hands-on experience using high-fidelity simulators.
This series of six hands-on workshops on tumour ablation
include a brief introduction and practical training in the
basic principles of all currently available ablation systems.
Each session is aimed at delegates with a specific level of
experience (core, intermediate or advanced). The round-table
discussions are themed around learning objectives which
relate to a specific clinical or procedural topic.
The delivery of each session is adaptable to respond to the
delegates’ interests, and emphasis is placed on small group
teaching, allowing close interaction with the expert faculty.
Equipment and devices will be available to demonstrate
deployment techniques.
Participants will have the opportunity to get familiar with
ablation equipment and to practice respective procedures
under in-vitro conditions using various systems. Moreover,
international experts will share their experience and insights
in an intimate atmosphere.
By the end of the workshop participants, even those with little
or no experience in tumour ablation, will be familiar with a
range of ablation techniques and will have learned tips and
tricks for a safe and efficacious clinical application.
Learning Objectives
PTP-HoW 1
08:30-13:00
PTP-HoW 2
08:30-13:00
PTP-HoW 3
08:30-13:00
PTP-HoW 4
08:30-13:00
Liver & kidney
– To understand the most appropriate indications for hepatic
and renal tumour ablation according to present guidelines
– To know how to choose the right ablation technique for each
lesion
– To understand the contraindications for local hepatic or renal
ablation techniques
– To understand how to enhance the efficacy of a specific
ablation technique with adjuvant techniques and how
to minimise or avoid the most commonly encountered
complications
C RSE
Hands-on Workshops
Lisbon 2015
39
Varicose Veins
Co-ordinators: J.A. Brookes (London/UK), L. Oguzkurt (Istanbul/TR)
Lung & thyroid gland
– To understand the most appropriate indications for
lung and thyroid tumour ablation according to present
guidelines
– To know how to choose the right ablation technique
for each lesion
– To understand the contraindications for local lung or
thyroid ablation techniques
to minimise or avoid the most commonly encountered
complications
Bone & soft tissue
– To understand the most appropriate indications for
bone tumour ablation according to present guidelines
and to know how to choose the right ablation technique
for each lesion
– To understand the contraindications for local bone
ablation techniques
to avoid or minimise the most commonly encountered
complications
– To become familiar with ultrasound-guided soft tissue
ablation
TA-HoW 1 – Liver & kidney
11:15-12:45
TA-HoW 2 – Liver & kidney
08:30-10:00
TA-HoW 3 – Lung & thyroid gland 08:30-10:00
TA-HoW 4 – Lung & thyroid gland 11:15-12:45
TA-HoW 5 – Bone & soft tissue
TA-HoW 6 – Bone & soft tissue
08:30-10:00
11:15-12:45
Endovenous treatment of symptomatic varicose veins has
become more and more accepted throughout Europe.
IRs are well suited to perform these therapies as they have
the required skills, but unfortunately many are not yet
familiar with the available techniques and devices.
This hands-on workshop provides an opportunity to gain
familiarity with the most commonly used techniques and
devices for endovenous therapy, including the handling of
different fibres and probes, and the corresponding generators. Participants will learn how to best access the vein with
ultrasound guidance, how to apply tumescent anaesthesia and
how to use the appropriate devices. In addition, participants
will be given the opportunity to gain insightful advice from
expert users.
Learning Objectives
– To learn about the different methods for endovenous
treatment
– To obtain practical experience with different devices
– To receive hands-on training in ultrasound-guided venous
access
– To learn the technique of tumescent anaesthesia
VV-HoW 1
11:15-12:45
VV-HoW 2
08:30-10:00
40
08:30-09:30
SS 101 Special Session
Venous Forum I: Varicose veins
08:30-10:00
CD-HoW 1 Hands-on Workshop
101.1 Patient selection, clinical and imaging assessment
J.A. Kaufman (Portland, OR/US)
101.2 Thermal ablation
101.3 Non-thermal ablation
M. Åkesson (Malmö/SE)
101.4 Ancillary therapies: mini-phlebectomy and foam
sclerotherapy
D.J. West (Stoke-on-Trent/UK)
08:30-09:30
Bariatric embolisation
102.1 Basic considerations, patient selection and
indication for treatment
M.P. Monteiro (Porto/PT)
102.2 Preclinical data
C.Y. Kim (Durham, NC/US)
102.3 Techniques and complications
C.R. Weiss (Baltimore, MD/US)
102.4 Early clinical results
C.R. Weiss (Baltimore, MD/US)
08:30-09:30
Management of early-stage hepatocellular
carcinoma
103.1 Diagnosis: imaging and biopsy
C. Ayuso (Barcelona/ES)
103.2 Staging, patient selection and treatment
algorithms
P.L. Pereira (Heilbronn/DE)
103.3 Ablation: techniques and complications
C.T. Sofocleous (New York, NY/US)
103.4 Outcomes of interventional treatments
L. Crocetti (Pisa/IT)
08:30-09:30
FC 104 Fundamental Course
Basic principles of acute stroke intervention
104.1 Current evidence on acute stroke intervention
G. Gál (Odense/DK)
104.2 Imaging algorithms and patient selection for
IA treatment
T. Engelhorn (Erlangen/DE)
104.3 IA stroke intervention: technique
A. Bonafé (Montpellier/FR)
104.4 Cerebral sinus thrombosis
C.P. Stracke (Essen/DE)
Co-ordinators: J.P. Schaefer (Kiel/DE),
R. Uberoi (Oxford/UK)
08:30-10:00
EMT-HoW 1 Hands-on Workshop
Embolisation: materials and tools –
coils & plugs
Co-ordinators: A. Martínez de la Cuesta
(Pamplona/ES), J.V. Patel (Leeds/UK)
08:30-13:00
PTP-HoW 1 Hands-on Workshop
Principles to practice: education and
simulation skills training
10:00-11:00
Basic principles of haemodialysis access
maintenance
201.1 Current evidence and indications for failing
dialysis access management
L. Turmel-Rodrigues (Tours/FR)
201.2 Thrombosed dialysis access
F.G. Irani (Singapore/SG)
201.3 Treatment of central vein occlusions
A.M. Madureira (Porto/PT)
201.4 Non-maturated dialysis access
S.O. Trerotola (Philadelphia, PA/US)
10:00-11:00
ICS 202 Interactive Case Session
Trauma bleeding
202.1 R. Uberoi (Oxford/UK)
202.2 A. Krajina (Hradec Králové/CZ)
C RSE
Lisbon 2015
10:00-11:00
Management of intermediate-advanced
hepatocellular carcinoma
203.1 Patient selection and treatment algorithms
R. Lencioni (Pisa/IT)
203.2 Conventional vs. drug-eluting bead embolisation
T. de Baère (Villejuif/FR)
203.3 Radioembolisation (TARE)
R. Salem (Chicago, IL/US)
203.4 Combined therapies in HCC: the evidence
J.-F.H. Geschwind (Baltimore, MD/US)
10:00-11:00
In-depth diagnostic and treatment concepts
in acute stroke
204.1 Where do we stand with "one-stop shop"
flat-panel angio-stroke imaging?
C. Stroszczynski (Regensburg/DE)
204.2 Role of imaging in patient selection for IV or
IA treatment: importance of imaging parameters
K.A. Hausegger (Klagenfurt/AT)
204.3 Direct recanalisation with or without stent
retrievers
A.S. Turk (Charleston, SC/US)
204.4 Current status of IA acute stroke treatment in light
of the MR CLEAN trial: the neurologist’s view
Y.B.W.E.M Roos (Amsterdam/NL)
10:00-11:00
Evidence Forum: Peripheral angioplasty
treatment for aorto-iliac occlusive disease?
A.M.H. Sailer (Maastricht/NL)
treatment for femoropopliteal disease?
treatment for infra-popliteal disease?
T. Rand (Vienna/AT)
treatment for visceral artery occlusive disease?
11:15-12:45
TA-HoW 1 Hands-on Workshop
Tumour ablation: tips and tricks –
liver & kidney
11:15-12:45
VV-HoW 1 Hands-on Workshop
Varicose veins
Co-ordinators: J.A. Brookes (London/UK),
11:30-12:30
SS 301 Special Session Controversy
Controversies in venous disease treatment
301.1 Pre-emptive dilation of stenoses
in dialysis access: pro
B.S. Tan (Singapore/SG)
301.2 Pre-emptive dilation of stenoses
in dialysis access: con
R. Shoenfeld (West Orange, NJ/US)
301.3 Permanent filters are obsolete: pro
O. Pellerin (Paris/FR)
301.4 Permanent filters are obsolete: con
S.D. Qanadli (Lausanne/CH)
301.5 Surgery for Paget Schroetter syndrome
is mandatory: pro
S. Black (London/UK)
301.6 Surgery for Paget Schroetter syndrome
is mandatory: con
G.J. O’Sullivan (Galway/IE)
11:30-12:30
Genitourinary embolisation
302.1 Uncontrolled post-partum haemorrhage
L. Ratnam (London/UK)
302.2 Pelvic congestion
A. Basile (Catania/IT)
302.3 Testicular varicocele
T. Jargiełło (Lublin/PL)
302.4 Prostate and bladder haemorrhage
M.A. de Gregorio (Zaragoza/ES)
41
42
11:30-12:30
Management of colorectal liver metastases
13:00-14:00
Satellite Symposia
303.1 Treating colorectal liver metastases with
liver-directed therapies: the medical oncologist’s
point of view
J. Taieb (Paris/FR)
303.2 Ablation in the modern oncological setting:
when and how
A. Gillams (London/UK)
303.3 HAIC, TACE or TARE?
P.E. Huppert (Darmstadt/DE)
303.4 Patient follow-up and when to re-intervene
M.C. Soulen (Philadelphia, PA/US)
11:30-12:30
Controversies in radiation safety
304.1 Dose optimisation is easy and improves
image quality: pro
E. Vano (Madrid/ES)
304.2 Dose optimisation is easy and improves
image quality: con
G. Bartal (Kfar-Saba/IL)
304.3 Real-time dose monitoring of staff makes
sense: pro
W. Jaschke (Innsbruck/AT)
304.4 Real-time dose monitoring of staff makes
sense: con
E.P. Efstathopoulos (Athens/GR)
304.5 Patient dose monitoring and recording
is essential: pro
G. Paulo (Coimbra/PT)
304.6 Patient dose monitoring and recording
is essential: con
R.W. Loose (Nuremberg/DE)
11:30-12:30
MEB 305 Multidisciplinary Expert Board
Tumour: hepatocellular carcinoma
Co-ordinator: R. Lencioni (Pisa/IT)
Panellists: Y. Arai (Tokyo/JP), M. Bezzi (Rome/IT),
J. Bruix (Barcelona/ES), U. Cillo (Padua/IT),
T. de Baère (Villejuif/FR)
14:30-16:00
OP 501 CIRSE Opening and Awards Ceremony
16:15-17:15
WS 601 Workshop
Complex DVT treatment: case-based
discussion
601.1 M.W. de Haan (Maastricht/NL)
601.2 M. Bratby (Oxford/UK)
16:15-17:15
WS 602 Workshop
Paediatric peripheral vascular and nonvascular interventions: case-based discussion
602.1 S. Sierre (Buenos Aires/AR)
602.2 S. Franchi-Abella (Le Kremlin Bicetre/FR)
16:15-17:15
WS 603 Workshop
Varicocele and ovarian vein embolisation:
case-based discussion
603.1 A. Antonietti (Cuneo/IT)
603.2 L. Machan (Vancouver/CA)
16:15-17:15
WS 604 Workshop
Ablation of MSK soft tissue tumours:
604.1 M.R. Callstrom (Rochester, MN/US)
604.2 A. Gangi (Strasbourg/FR)
16:15-17:15
WS 605 Workshop
Treatment planning and advanced image
guidance: case-based discussion
605.1 M.J.L. van Strijen (Nieuwegein/NL)
605.2 T. de Baère (Villejuif/FR)
16:15-17:15
WS 606 Workshop
Cerebral dural AVFs and pial AVMs:
606.1 M. Muto (Naples/IT)
606.2 S. Mangiafico (Florence/IT)
C RSE
Lisbon 2015
16:15-17:15
Free Papers
16:15-17:15
Satellite Symposia
17:30-18:30
WS 701 Workshop
Challenging haemodialysis access
interventions: case-based discussion
701.1 M. Tsitskari (Athens/GR)
701.2 C. Hohl (Siegen/DE)
17:30-18:30
WS 702 Workshop
Venous sampling: case-based discussion
17:30-18:30
WS 704 Workshop
Challenging urinary tract interventions:
704.1 C. Tapping (Oxford/UK)
704.2 M. Szczerbo-Trojanowska (Lublin/PL)
17:30-18:30
WS 705 Workshop
Tips and tricks for challenging liver ablations:
705.1 C.T. Sofocleous (New York, NY/US)
705.2 R. Bale (Innsbruck/AT)
17:30-18:30
Satellite Symposia
702.1 S.O. Trerotola (Philadelphia, PA/US)
702.2 L.J. Schultze Kool (Nijmegen/NL)
17:30-18:30
WS 703 Workshop
Complex microcatheterisation techniques:
703.1 F. Pozzi-Mucelli (Trieste/IT)
703.2 A. Fohlen (Caen/FR)
43
44
08:30-09:30
Basic principles of biliary intervention
901.1 Biliary interventions for stone disease
E. Brountzos (Athens/GR)
901.2 Biliary interventions in bile duct malignancy
H.-U. Laasch (Manchester/UK)
901.3 Biliary leak and iatrogenic bile duct injury
management
O.M. van Delden (Amsterdam/NL)
901.4 Biliary interventions in liver transplant patients
J.H. Peregrin (Prague/CZ)
08:30-09:30
How to improve acute stroke management:
new horizons
902.1 How can imaging improve patient selection for
mechanical thrombectomy or IV thrombolysis?
P. Michel (Lausanne/CH)
902.2 New generation stent retrievers
T. Andersson (Kortrijk/BE)
902.3 MR guidance in endovascular acute stroke
intervention with new magnetically-assisted,
remote-controlled catheters
S. Hetts (San Francisco, CA/US)
902.4 IA stem cell therapy in stroke patients
S. Banerjee (London/UK)
08:30-09:30
Embolic agents for microcatheters
903.1 Microcoils
L. Defreyne (Ghent/BE)
903.2 Microparticles
K. Osuga (Osaka/JP)
903.3 Ethylene vinyl alcohol
W.A. Wohlgemuth (Regensburg/DE)
903.4 Acrylic glue
Y. Arai (Tokyo/JP)
08:30-09:30
Venous Forum II: Deep vein thrombosis
904.1 Trials update and current evidence
S. Kee (Los Angeles, CA/US)
904.2 Patient selection and treatment: upper limb DVT
V. Bérczi (Budapest/HU)
904.3 Patient selection and treatment: lower limb DVT
J. Kettenbach (St. Pölten/AT)
904.4 Chronic iliac vein and caval occlusion
R. de Graaf (Maastricht/NL)
08:30-09:30
LS 905 Lecture Session
Abdominal aorta
905.1 Device evolution and impact on EVAR outcomes
P. Vilares Morgado (Porto/PT)
905.2 Is there still a role for AUI stentgrafts in EVAR?
M. Schoder (Vienna/AT)
905.3 Is thrombus in the neck a contraindication
for EVAR?
P. Cao (Rome/IT)
905.4 Is there a need to preserve internal iliac arteries?
L.B. Lönn (Copenhagen/DK)
905.5 A fit 65-year-old patient with AAA suitable for
EVAR should undergo open surgery
tba
905.6 A fit 65-year-old patient with AAA suitable for
EVAR should not undergo open surgery
M.W. de Haan (Maastricht/NL)
08:30-10:00
liver & kidney
08:30-10:00
VV-HoW 2 Hands-on Workshop
Varicose veins
Co-ordinators: J.A. Brookes (London/UK),
C RSE
Lisbon 2015
08:30-13:00
10:00-11:00
Basic principles of biopsy and drainage
procedures
1001.1 Percutaneous biopsy of easy and difficult lesions
in the lungs and mediastinum
P.A.M.S. Almeida (Viseu/PT)
1001.2 Percutaneous treatment of empyema, lung
abscess and mediastinal abscess
M. Düx (Frankfurt/DE)
1001.3 Percutaneous biopsy of easy and difficult lesions
in the abdomen and pelvis
O. Akhan (Ankara/TR)
1001.4 Percutaneous management of abdominal and
pelvic fluid collections
M.J. Lee (Dublin/IE)
10:00-11:00
Acute stroke revascularisation: from simple to
challenging
1002.1 A.S. Turk (Charleston, SC/US)
1002.2 I.Q. Grunwald (Oxford/UK)
10:00-11:00
State-of-the-art vascular malformation
management
1003.1 Diagnosis and treatment: low-flow malformations
B. Peynircioglu (Ankara/TR)
1003.2 Diagnosis and treatment: high-flow malformations
M. Köcher (Olomouc/CZ)
1003.3 Diagnosis and treatment: large visceral vascular
malformations
J.E. Jackson (London/UK)
1003.4 Diagnosis and treatment: paediatric vascular
malformations
10:00-11:00
Controversies in arterial intervention
1004.1 Renal denervation is dead: pro
J.A. Reekers (Amsterdam/NL)
1004.2 Renal denervation is dead: con
M.R. Sapoval (Paris/FR)
1004.3 Popliteal stents are effective: pro
M. Cejna (Feldkirch/AT)
1004.4 Popliteal stents are effective: con
H. Kobeiter (Créteil/FR)
1004.5 ICSS long-term data will lead to resurgence
of CAS: pro
A.H. Mahnken (Marburg/DE)
1004.6 ICSS long-term data will lead to resurgence
of CAS: con
10:00-11:00
Palliation in cancer: alleviation strategies
1005.1 Plexus block for pain management
J. Garnon (Strasbourg/FR)
1005.2 GI obstruction
R. Patel (Oxford/UK)
1005.3 Long-term drainage of malignant pleural effusion
and ascites
K.E. Wilhelm (Bonn/DE)
1005.4 Lymphatic leaks
W. Prevoo (Amsterdam/NL)
10:00-11:00
Aortic dissection
1006.1 Outcomes of endovascular treatment of
complicated type B dissection (IRAD)
1006.2 "Petticoat" technique: indications and results
E. Ducasse (Bordeaux/FR)
1006.3 Management of distal re-entry tear:
when and how
C. Ferro (Genoa/IT)
1006.4 Fenestrated and branched grafts to treat
post-dissection aneurysm
E. Verhoeven (Nuremberg/DE)
1006.5 For the motion
1006.6 Against the motion
tba
45
46
11:15-12:45
CD-HoW 2 Hands-on Workshop
16:15-17:15
WS 1401 Workshop
Challenging lower limb interventions:
Co-ordinators: J.P. Schaefer (Kiel/DE),
1401.1 M. Katoh (Krefeld/DE)
1401.2 D. Karnabatidis (Patras/GR)
11:15-12:45
coils & plugs
16:15-17:15
WS 1402 Workshop
Prostate artery embolisation:
1402.1 H. Rio Tinto (Lisbon/PT)
1402.2 T. Sabharwal (London/UK)
11:30-12:30
Satellite Symposia
16:15-17:15
WS 1403 Workshop
Management of anticoagulation and
antiplatelet therapy
11:30-12:30
Optimising radiation protection in
interventional radiology: what can the
radiographer do?
1403.1 L. Kamper (Wuppertal/DE)
1403.2 M. Rosales Sueiro (Porto/PT)
16:15-17:15
WS 1404 Workshop
Flow modification in cerebral aneurysms:
creating new treatment alternatives
1104.1 S. Mc Fadden (Belfast/UK)
1104.2 R. Gould (Belfast/UK)
13:00-14:00
Satellite Symposia
1404.1 S. Cekirge (Ankara/TR)
14:30-15:30
Satellite Symposium
16:15-17:15
Free Papers
14:30-16:00
Honorary Lecture / Hot Topic Symposium
16:15-17:15
AI 1409 Amazing Interventions
14:30-15:00
HL 1301 Andreas Gruentzig Lecture
Co-ordinator: R.A. Morgan (London/UK)
16:15-17:15
ART 1410 Aortic Round Table
Abdominal aorta
1301.1 Advanced image modelling of abdominal aortic
aneurysm: impact on EVAR management
G. Soulez (Montreal/CA)
15:00-16:00
HTS 1302 Aortic intervention – quo vadis?
1302.1 Thoracic aortic trauma
1302.2 Complicated acute type B dissection
1302.3 Malperfusion syndromes in acute aortic dissection
J.-P. Beregi (Nîmes/FR)
1302.4 Ruptured abdominal aortic aneurysm
F.J. Veith (New York, NY/US)
1410.1 Customised follow-up in EVAR
tba
1410.2 Technique selection in the devious proximal neck
1410.3 Management of RAAA
J.C. Parodi (Buenos Aires/AR)
1410.4 Management of aorto-iliac aneurysms
C RSE
Lisbon 2015
17:30-18:30
WS 1501 Workshop
The challenging diabetic foot: case-based
discussion
1501.1 K.N. Katsanos (London/UK)
1501.2 R.J. Hinchliffe (London/UK)
17:30-18:30
WS 1503 Workshop
Practical issues in dose optimisation and
monitoring during IR procedures
1503.1 G. Bartal (Kfar-Saba/IL)
1503.2 E. Vano (Madrid/ES)
17:30-18:30
Free Papers
17:30-18:30
WS 1502 Workshop
Intractable arterial gastrointestinal bleeding:
1502.1 M.A. Funovics (Vienna/AT)
1502.2 J. Golzarian (Minneapolis, MN/US)
17:30-18:30
Satellite Symposia
17:30-18:30
Abdominal aorta
1510.1
1510.2
1510.3
1510.4
J.F. Benenati (Miami, FL/US)
C.D. Liapis (Athens/GR)
tba
47
48
08:30-09:30
Basic principles of transcatheter embolisation
in the trauma patient
1705.1 Technical issues in thoraco-abdominal branched
grafting
E. Verhoeven (Nuremberg/DE)
1705.2 Off-the-shelf endografts for TAAA: benefits and
limitations
C. Bicknell (London/UK)
1705.3 Current status of arch branched repair
N. Mangialardi (Rome/IT)
1705.4 Hybrid procedures for aortic arch disease
T.A. Resch (Malmö/SE)
1705.5 The left subclavian artery can be covered in most
TEVAR cases without revascularisation: pro
F. Fanelli (Rome/IT)
1705.6 The left subclavian artery can be covered in most
TEVAR cases without revascularisation: con
1701.1 Treatment of extremity trauma
S.J. McPherson (Leeds/UK)
1701.2 Treatment of parenchymatous bleeding in
abdominal cavity
J. Urbano (Madrid/ES)
1701.3 Treatment of pelvic haemorrhage
W. Jaschke (Innsbruck/AT)
1701.4 Role of stent grafts in large vessel trauma
F. Wolf (Vienna/AT)
08:30-09:30
Venous Forum III: Pulmonary embolism and
IVC filters
1702.1 PE: patient assessment and selection for treatment
M.K. Glynos (Athens/GR)
1702.2 Treatment options for pulmonary embolism
P.M. Paprottka (Munich/DE)
1702.3 Current evidence on IVC filter placement
M.-F. Giroux (Montreal/CA)
1702.4 Challenging placements and retrievals
C.A. Binkert (Winterthur/CH)
08:30-09:30
State-of-the-art SFA interventions
1703.1 Trials update
1703.2 Techniques and complication management
M.A. Ruffino (Turin/IT)
1703.3 Are stent grafts the best option?
M. Schoder (Vienna/AT)
1703.4 Treatment options and cost effectiveness
P. Reimer (Karlsruhe/DE)
08:30-09:30
Management of renal malignancies
1704.1 Triage of the renal cancer patient
X. Buy (Bordeaux/FR)
1704.2 Ablation vs. nephron-sparing surgery:
the evidence
D.J. Breen (Southampton/UK)
1704.3 Ablation: what’s new?
J. Tacke (Passau/DE)
1704.4 Is there any role for intra-arterial therapies?
E. Boatta (Rome/IT)
08:30-09:30
Complex thoracic aorta
08:30-10:00
liquid agents
08:30-10:00
lung & thyroid gland
08:30-13:00
C RSE
Lisbon 2015
10:00-11:00
Basic principles of transcatheter embolisation
in thoracic haemorrhage
1801.1 Treatment of bronchial artery bleeding
M. Szczerbo-Trojanowska (Lublin/PL)
1801.2 Treatment of pulmonary artery aneurysms
J.A. Vos (Nieuwegein/NL)
1801.3 Treatment of thoracic wall and aortic arch
branches haemorrhage
T. Sabharwal (London/UK)
1801.4 Thoracic duct embolisation
W. Prevoo (Amsterdam/NL)
10:00-11:00
State-of-the-art visceral artery aneurysm
and pseudoaneurysm management
1802.1 Epidemiology, clinical presentation and imaging
P. Vilares Morgado (Porto/PT)
1802.2 Current evidence and patient triage
L.P. Lawler (Dublin/IE)
1802.3 Stentgrafts and embolisation: technique
M.S. Hamady (London/UK)
1802.4 Periprocedural care and patient follow-up
P.P. Goffette (Brussels/BE)
10:00-11:00
State-of-the-art BTK interventions
1803.1 Trials update
H. van Overhagen (The Hague/NL)
1803.2 Techniques and complication management
L.M. Palena (Abano Terme/IT)
1803.3 Wound care and patient follow-up
K.N. Katsanos (London/UK)
1803.4 Bioresorbable vascular scaffolds
tba
10:00-11:00
Difficult and unusual tumour ablations
1804.1 A. Gangi (Strasbourg/FR)
1804.2 L. Solbiati (Busto Arsizio/IT)
10:00-11:00
Credibility and value for money:
the keys to success
1805.1 Cost effectiveness in medicine: what is it, and how
do you measure it?
P. McCrone (London/UK)
1805.2 Quality assurance and value for money: how IR
can prove its worth
L.M. Kenny (Brisbane/AU)
1805.3 Comparative effectiveness research: IR states its case
R. Lencioni (Pisa/IT)
1805.4 Next important steps for IR
A. Adam (London/UK)
10:00-11:00
Complex abdominal aorta
1806.1 Adverse neck anatomy is progressive despite initial
successful EVAR: implications for technique and
device selection
T.M. Mastracci (London/UK)
1806.2 Fenestrated grafts vs. open surgery in
juxtarenal AAA
J.-P. Becquemin (Créteil/FR)
1806.3 Tips and tricks for FEVAR
R.G. McWilliams (Liverpool/UK)
1806.4 EVAR with short neck: the role of chimney
technique
F.E. Vermassen (Ghent/BE)
1806.5 Short necks can be treated by standard EVAR using
new devices
tba
1806.6 Short necks need more advanced endovascular
techniques
M.A. Funovics (Vienna/AT)
11:15-12:45
liquid agents
11:15-12:45
lung & thyroid gland
49
50
11:30-12:30
Satellite Symposia
16:15-17:15
WS 2202 Workshop
Iatrogenic and non-iatrogenic trauma:
11:30-12:30
Management of pain during IR procedures
2202.1 S.J. Park (Incheon/KR)
2202.2 M. Černá (Olomouc/CZ)
1904.1 A. England (Salford/UK)
1904.2 S. Morse (Manchester/UK)
16:15-17:15
WS 2203 Workshop
Challenging biliary interventions:
13:00-14:00
Satellite Symposia
14:30-15:30
Satellite Symposium
2203.1 M.E. Krokidis (Cambridge/UK)
2203.2 B. Gonçalves (Porto/PT)
14:30-15:15
XS 2101 The X-Session
Speakers: A. Adam (London/UK), J. Lammer (Vienna/AT),
M.J. Lee (Dublin/IE), J.H. Peregrin (Prague/CZ),
J.A. Reekers (Amsterdam/NL), D. Vorwerk (Ingolstadt/DE)
15:15-16:00
FI 2102 Film Interpretation Quiz
Co-ordinators: O.M. van Delden (Amsterdam/NL),
A.F. Watkinson (Exeter/UK)
14:30-15:30
ART 2103 Aortic Round Table
Thoracic aorta
2103.1 Arch aneurysm management
M.D. Dake (Stanford, CA/US)
2103.2 Paraplegia prevention and management
in TAAA branched grafting
S. Haulon (Lille/FR)
2103.3 Management of complications of chronic
dissection
2103.4 Acute type B dissection
16:15-17:15
WS 2201 Workshop
Acute lower limb ischaemia:
16:15-17:15
WS 2204 Workshop
Lung and kidney ablation:
2204.1 R.F. Grasso (Rome/IT)
2204.2 C.S. Georgiades (Nicosia/CY)
16:15-17:15
Free Papers
16:15-17:15
General Assembly
16:15-17:15
Aortic disease
Co-ordinators: K.A. Hausegger (Klagenfurt/AT),
C.D. Liapis (Athens/GR)
Panellists: M.D. Dake (Stanford, CA/US),
M. Jenkins (London/UK), J.C. Parodi (Buenos Aires/AR)
17:30-18:30
WS 2301 Workshop
The difficult IVC filter:
2301.1 tba
2301.2 D.A. Valenti (Montreal/CA)
2201.1 A. Buecker (Homburg/DE)
2201.2 J.-P. Beregi (Nîmes/FR)
C RSE
Lisbon 2015
17:30-18:30
WS 2302 Workshop
The difficult vascular malformation:
2302.1 P. Waldenberger (Salzburg/AT)
2302.2 B. Peynircioglu (Ankara/TR)
17:30-18:30
WS 2303 Workshop
Interventional management of pancreatitis:
2303.1 O. Akhan (Ankara/TR)
2303.2 V. Válek (Brno/CZ)
17:30-18:30
Free Papers
17:30-18:30
Satellite Symposia
17:30-18:30
Ruptured AAA
2310.1 Organisational requirements for effective
endovascular RAAA treatment
A. Chavan (Oldenburg/DE)
2310.2 What is the evidence for permissive hypotension
in RAAA?
G. Nicholson (London/UK)
2310.3 SWEDVASC Registry: primary EVAR or primary
open strategy for ruptured AAA
K. Mani (Uppsala/SE)
2310.4 Is there a role for chimney and periscopes in shortnecked ruptured AAA
M.W. de Haan (Maastricht/NL)
2310.5 Endovascular treatment is equal to open surgery
2310.6 Endovascular treatment is not equal to open
surgery
J. Lammer (Vienna/AT)
51
52
08:30-09:30
Imaging of the aorta
08:30-09:30
Men’s health – basic principles of BPH
treatment
2501.1 Indication for treatment – patient triage
M.R. Sapoval (Paris/FR)
2501.2 Current evidence on prostate artery embolisation
N. Hacking (Southampton/UK)
2501.3 Prostate artery embolisation: technique
F.C. Carnevale (São Paulo/BR)
2501.4 Tips and tricks for difficult PAE procedures
T. Bilhim (Lisbon/PT)
08:30-09:30
State-of-the-art aorto-iliac disease treatment
2502.1 Current evidence and practice since TASC II
P. Minko (Homburg/DE)
2502.2 Treatment of bifurcational lesions
D.K. Tsetis (Iraklion/GR)
2502.3 Treatment of long occlusions
K. Schürmann (Dortmund/DE)
2502.4 Treatment of iliac aneurysms
G.S. Goh (Melbourne/AU)
08:30-10:00
particulate agents
08:30-09:30
HCC in liver transplantation
2503.1 Patient selection and criteria for organ allocation
V. Mazzaferro (Milan/IT)
2503.2 Imaging before transplantation
V. Vilgrain (Clichy/FR)
2503.3 The role of bridging therapies
M.C. Burgmans (Leiden/NL)
2503.4 Downstaging
N. Goldberg (Jerusalem/IL)
08:30-09:30
Quality in IR
2505.1 Should we use 3D ultrasound for AAAs?
tba
2505.2 Does MR have a role in pre- and post-procedural
imaging?
D.A. Brisbois (Liège/BE)
2505.3 The use of robotics to perform EVAR
M.S. Hamady (London/UK)
2505.4 The increasing role of fusion imaging in
endovascular aortic procedures
G.M. Richter (Stuttgart/DE)
2505.5 Duplex ultrasound should replace CTA for
post-EVAR surveillance
tba
2505.6 Low-dose CTA is superior to CDUS for post-EVAR
surveillance
C.M. Loewe (Vienna/AT)
08:30-10:00
bone & soft tissue
08:30-13:00
2504.1 Influence of data on quality
P. Reimer (Karlsruhe/DE)
2504.2 Influence of checklist use on patient safety
M.J. Lee (Dublin/IE)
2504.3 Influence of standardisation on outcome
(CIRSE guidelines)
T.J. Kroencke (Augsburg/DE)
2504.4 Factors influencing patient satisfaction
T.J. Cleveland (Sheffield/UK)
C RSE
Lisbon 2015
10:00-11:00
Women’s health – basic principles of UAE for
symptomatic fibroids
2601.1 Indication for treatment – patient triage
J.B. Spies (Washington, DC/US)
2601.2 Pre-procedural imaging, patient preparation and
medication
H. Vernhet-Kovacsik (Montpellier/FR)
2601.3 Tips and tricks for difficult UAE procedures
P.N.M. Lohle (Tilburg/NL)
2601.4 Procedural complications and pain management
J.-P. Pelage (Caen/FR)
10:00-11:00
Evidence Forum: Drug-eluting devices
2602.1 Drug-eluting devices in supra-aortic lesions
R. Gandini (Rome/IT)
2602.2 Drug-eluting devices in haemodialysis access
R.H. Portugaller (Graz/AT)
2602.3 Drug-eluting devices in SFA lesions
P. Krishnan (New York, NY/US)
2602.4 Drug-eluting devices in BTK lesions
N. Chalmers (Manchester/UK)
10:00-11:00
Trials and current evidence in interventional
oncology
2603.1 TACE
K. Malagari (Athens/GR)
2603.2 Radioembolisation
J.I. Bilbao (Pamplona/ES)
2603.3 Microwave and cryoablation
G. Narayanan (Miami, FL/US)
2603.4 HIFU and IRE
M. Bezzi (Rome/IT)
10:00-11:00
State-of-the-art spinal tumour interventions
2604.1 Procedural approach and bone biopsy
D.K. Filippiadis (Athens/GR)
2604.2 Percutaneous treatment of benign tumours
G. Tsoumakidou (Strasbourg/FR)
2604.3 Percutaneous treatment of malignancies
F. Deschamps (Villejuif/FR)
2604.4 Embolisation
A.G. Ryan (Waterford City/IE)
10:00-11:00
CM 2605 CIRSE meets
CIRSE meets China
2605.1 Percutaneous transhepatic portosystemic shunt
2605.2 Stent loaded with 125I seeds in malignancies –
from bench to bedside
G.-J. Teng (Nanjing/CN)
2605.3 Hybrid intervention for complex cerebrovascular
disease
W.-J. Jiang (Beijing/CN)
10:00-11:00
Thoracic aorta
2606.1
2606.2
2606.3
2606.4
tba
M.A. Funovics (Vienna/AT)
M.P. Jenkins (London/UK)
11:15-12:45
particulate agents
11:15-12:45
bone & soft tissue
11:30-12:30
GI tract haemorrhage
2701.1 Clinical evaluation and imaging of GI bleeding
D.A. Brisbois (Liège/BE)
2701.2 Treatment and outcome: upper GI bleeding
P.E. Bize (Lausanne/CH)
2701.3 Treatment and outcome: lower GI bleeding
P.F. Sousa (Porto/PT)
2701.4 Diagnosis and treatment of chronic GI bleeding
V. Vidal (Marseille/FR)
53
54
11:30-12:30
State-of-the-art endovascular thrombectomy
2702.1 Lower extremity aspiration thrombectomy
M. Katoh (Krefeld/DE)
2702.2 Visceral artery thrombectomy
J. Raupach (Hradec Králové/CZ)
2702.3 Venous thrombectomy
G.J. O’Sullivan (Galway/IE)
2702.4 Mechanical intracranial thrombectomy
C.P. Stracke (Essen/DE)
11:30-12:30
Transcatheter embolisation in liver metastatic
disease
2703.1 Neuroendocrine liver metastases
B.A. Radeleff (Heidelberg/DE)
2703.2 CRC liver metastases
A. Denys (Lausanne/CH)
2703.3 Other liver metastases
K.P. van Lienden (Amsterdam/NL)
2703.4 Portal vein embolisation
M. Das (Maastricht/NL)
2706.1 EndoAnchors to fix type I endoleaks: can they
replace Palmaz stents and/or cuffs?
D. Böckler (Heidelberg/DE)
2706.2 Type II endoleaks: management options
F. Pozzi-Mucelli (Trieste/IT)
2706.3 Re-intervention after fenestrated and branched
endovascular repair
R.A. Morgan (London/UK)
2706.4 Treatment of limb occlusions and how to prevent
them
G.A. Maleux (Leuven/BE)
2706.5 For the motion
J.F. Benenati (Miami, FL/US)
2706.6 Against the motion
tba
13:00-14:00
Satellite Symposia
14:30-15:30
Satellite Symposium
14:30-16:00
Honorary Lecture / Hot Topic Symposium
11:30-12:30
Malignant bone tumours: current evidence
and new frontiers
14:30-15:00
HL 2901 Josef Roesch Lecture
2704.1 Focal treatment: when and how
M.R. Callstrom (Rochester, MN/US)
2704.2 Pain palliation of bone metastases
A.D. Kelekis (Athens/GR)
2704.3 Fractures: prevention and treatment
J. Garnon (Strasbourg/FR)
2704.4 The potential of high-intensity focused ultrasound
A. Napoli (Rome/IT)
11:30-12:30
PAD: carotid stenosis (conservative/medical,
CEA, CAS)
11:30-12:30
Endoleaks and complications
2901.1 CLI beyond pipe fitting
15:00-16:00
HTS 2902 Paediatric IR – expand your horizons
2902.1 Aneurysmal bone cysts
P. Warren (Columbus, OH/US)
2902.2 Lymphatic malformations of the orbit
2902.3 Lymphatic intervention in children
M. Itkin (Philadelphia, PA/US)
2902.4 Thrombolysis in children and adolescents
A.M. Cahill (Philadelphia, PA/US)
Co-ordinator: D. Vorwerk (Ingolstadt/DE)
Panellists: tba
C RSE
Lisbon 2015
16:15-17:15
WS 3001 Workshop
Challenging supra-aortic interventions:
3001.1 P. Brennan (Dublin/IE)
3001.2 J.C. van den Berg (Lugano/CH)
16:15-17:15
WS 3002 Workshop
Advanced techniques for managing CLI:
3002.1 R. Gandini (Rome/IT)
3002.2 H. van Overhagen (The Hague/NL)
16:15-17:15
WS 3003 Workshop
Preparation for EBIR and the use of
ESIRonline
3003.1 K.A. Hausegger (Klagenfurt/AT)
3003.2 M. Bezzi (Rome/IT)
16:15-17:15
WS 3004 Workshop
Basic and advanced Y-90:
17:30-18:30
WS 3101 Workshop
Challenging varicose vein ablation:
3101.1 J.A. Kaufman (Portland, OR/US)
3101.2 K.D. McBride (Dunfermline/UK)
17:30-18:30
WS 3102 Workshop
Challenging visceral artery aneurysms:
3102.1 G.J. Robinson (Hull/UK)
3102.2 P. Chabrot (Clermont-Ferrand/FR)
17:30-18:30
WS 3103 Workshop
Complications of abdominal surgery
treatment: case-based discussion
3103.1 P. Lucatelli (Rome/IT)
3103.2 T. Pfammatter (Zurich/CH)
17:30-18:30
Free Papers
17:30-18:30
Satellite Symposium
3004.1 J.I. Bilbao (Pamplona/ES)
3004.2 C. Ferro (Genoa/IT)
16:15-17:15
Free Papers
16:15-17:15
Satellite Symposium
55
56
08:30-09:30
Venous Forum IV: Portal hypertension
3201.1 TIPS for refractory ascites and variceal bleeding
É. Coimbra (Lisbon/PT)
3201.2 Percutaneous treatment options in portal vein
thrombosis
A. Krajina (Hradec Králové/CZ)
3201.3 Percutaneous management of Budd-Chiari
syndrome
I.K. Tesdal (Friedrichshafen/DE)
3201.4 BRTO – why, when and how?
K. Kichikawa (Nara/JP)
08:30-09:30
State-of-the-art biliary and pancreatic
malignancy treatment
3202.1 Intrahepatic cholangiocarcinoma: interventional
treatments
W.S. Rilling (Milwaukee, WI/US)
3202.2 Hilar cholangiocarcinoma: palliation strategies
T. Andrašina (Brno/CZ)
3202.3 IRE for pancreatic tumours: the evidence
A. Nilsson (Uppsala/SE)
3202.4 HIFU for pancreatic tumours: the evidence
F. Orsi (Milan/IT)
08:30-09:30
How to deliver high-quality IR services
3203.1 IR as clinical specialty
D.K. Tsetis (Iraklion/GR)
3203.2 Provision of IR: requirements
3203.3 24/7 access to IR services
A.M. Al-Kutoubi (Beirut/LB)
3203.4 Efficient workforce planning
G. Mühlenbruch (Würselen/DE)
10:00-11:00
State-of-the-art pedal angioplasty
3301.1 Current evidence
H.I. Manninen (Kuopio/FI)
3301.2 Access routes and technical considerations
M.G. Manzi (Abano Terme/IT)
3301.3 Procedural complications and their management
L.M. Palena (Abano Terme/IT)
3301.4 Special considerations in the diabetic patient
10:00-11:00
Lung metastases: facts and controversies
3302.1 Patient triage for lung metastases: where is the
evidence?
J. Palussière (Bordeaux/FR)
3302.2 Ablation of lung tumours: present and future
J.-Y. Gaubert (Marseille/FR)
3302.3 Radiation therapy for lung tumours: with or
without ablation?
M.D. Piroth (Wuppertal/DE)
3302.4 Treatment options and cost effectiveness
A.H. Mahnken (Marburg/DE)
10:00-11:00
Complex venous interventions
3303.1 B. Gebauer (Berlin/DE)
3303.2 G.A. Maleux (Leuven/BE)
11:30-12:30
MM 3401 Morbidity & Mortality Conference
Co-ordinators: T.K. Helmberger (Munich/DE),
F. Wolf (Vienna/AT)
C RSE
57
Lisbon 2015
STAY IN THE LOOP ALL YEAR ROUND
with the CIRSE App
• Your mobile portal for all CIRSE resources:
fast access to esir.org and cirse.org
• Get the latest news from CIRSE,
updated throughout the year
• Find all future CIRSE event programmes in one app
and use your mobile device to navigate and
personalise your congress experience!
Cardiov
ascular
and Int
erve
ntional
Radiolo
gical So
ciety
C RSE
C RSE
news
INNOVA
esir.org
cirse.org
ECIO
IR E
T E R V ES
201T I5O N | I N C
2015N T I O N
TION |
EDUCA
of Euro
pe
58
General Information
General Information
Congress Dates
CIRSE 2015 will take place from September 26-30, 2015.
Congress Venue
Centro de Congressos de Lisboa
Praça das Indústrias
1300-307 Lisbon | Portugal
Phone: +351 213 601 400 | Fax: +351 213 601 499
Email: [email protected]
CIRSE Secretariat
CIRSE Central Office
Neutorgasse 9
1010 Vienna | Austria
Phone: +43 1 904 2003 | Fax: +43 1 904 2003-30
Exhibition Management
MAW
Bettina Kreiner, Dominik Udolf, Simone Weinmann
Phone: +43 1 536 63-35, -64, -37 | Fax: +43 1 535 6016
Accommodation
Kuoni Destination Management
operated by
Buzz Portugal DMC
Av. Elias Garcia, n° 147, 5° Esq
1050-099 Lisbon | Portugal
Phone: +351 211 147 160
CME Credit Allowance
European Accreditation will be applied for at the EACCME
(European Accreditation Council for Continuing Medical
Education) in order to validate the credits in CIRSE participants’
European home countries. The EACCME is an institution of the
European Union of Medical Specialists (UEMS), www.uems.net.
C RSE
Registration
Lisbon 2015
59
Congress Registration
Register before June 18, 2015 and benefit from reduced early bird registration fees!
Online registration (secured payment) for CIRSE 2015 and IDEAS 2015 will be available from March onwards on www.cirse.org.
Please note that your registration must be submitted and all fees paid by the respective deadlines. Incomplete registrations
(not containing full name and address) cannot be processed.
Registration fees for CIRSE 2015 (€)
CIRSE 2015
Early Bird Fee
Until June 18, 2015
CIRSE Member
Non-Member
Resident* (CIRSE Member)
Resident* (Non-Member)
Nurse/Radiographer* (CIRSE Member)
Nurse/Radiographer* (Non-Member)
Undergraduate Medical European Student**
€ 480
€ 780
€ 270
€ 330
€ 190
€ 300
€ 0
After June 18, 2015
CIRSE Member
Non-Member
Undergraduate Medical European Student**
€ 680
€ 980
€ 475
€ 560
€ 440
€ 550
€ 0
* to be accompanied by a certificate signed by the
Head of Department
** for undergraduate medical European students. Students’
registrations must be accompanied by a certificate or letter
from their university, confirming their undergraduate medical
student status, by a copy of a valid ID and a one-page CV.
Your registration fee includes
• access to CIRSE 2015 and IDEAS 2015 – The Interdisciplinary
Endovascular Aortic Symposium (www.aorticideas.org)
• access to the CIRSE 2015 Technical Exhibition, Satellite
Symposia and industry sponsored Learning Centres
• one year access to ESIRonline (www.esir.org), the educational
platform for interventional radiology
Reduced registration fees are only available for members who
have been in good standing during the years 2014 and 2015
(individuals who become CIRSE Members in 2015 will be able
to benefit from reduced congress fees for the meeting in 2016).
Method of payment
Registration fees are to be paid in Euros (€) by:
• Bank Transfer or
• Credit Card (Visa or Mastercard)
Cancellation of congress registration
CIRSE offers all participants the possibility of taking out
cancellation insurance with our partner, Europäische
Reiseversicherung (see www.cirse.org). CIRSE will not provide
refunds after a cancellation of registration. All requests for
refund have to be issued to Europäische Reiseversicherung.
Registration fees for IDEAS 2015 (€)
Early Bird Fee
Until June 18, 2015
CIRSE Member
Non-Member
€ 380
€ 580
€ 260
€ 320
€ 180
€ 290
After June 18, 2015
CIRSE Member
Non-Member
€ 480
€ 780
€ 420
€ 550
€ 360
€ 460
* to be accompanied by a certificate signed by the Head of
Department
Your registration fee includes
• access to IDEAS 2015 – The Interdisciplinary Endovascular
Aortic Symposium (www.aorticideas.org) from
September 27-29 (two and a half days)
• access to the CIRSE 2015 Technical Exhibition, Satellite
Symposia and industry sponsored Learning Centres from
September 27-29 (two and a half days)
• one year access to ESIRonline (www.esir.org), the educational
platform for interventional radiology
Name changes will be handled as a cancellation and
new registration.
Additional information
All CIRSE 2015 and IDEAS 2015 registrants will be able to print
out an invoice of the registration using their personal log-in
details at www.cirse.org.
Invoices will be issued by:
CIRSE Congress Research Education GmbH,
Neutorgasse 9, 1010 Vienna, Austria
Further information on registration
is available at www.cirse.org
A W E A LT H O F I R L E A R N I N G
CIRSE members benefit from a special service:
over 8,000 presentations, webcasts and abstracts
from CIRSE events since 2006 are available on
ESIRonline, year-round.
Log into ESIRonline at www.esir.org using your
myCIRSE details and explore the most extensive
online educational resource in interventional radiology,
featuring the latest congress recordings as well
as specially compiled topic packages!
www.esir.org
Lisbon 2015
Exhibitors
Exhibitors
The CIRSE Annual Scientific and postgraduate Educational Meeting has established itself as the leading gathering for all
professionals devoted to the field of cardiovascular and interventional radiology in Europe. CIRSE 2014 saw an attendance
of over 6,400 participants from 78 countries worldwide. More than 100 companies took the opportunity to promote their
products.
CIRSE’s technical exhibition features the largest and most comprehensive assembly of cutting edge equipment and devices
for image-guided minimally invasive therapy in Europe. CIRSE would like to thank the following companies for their
participation at CIRSE 2014 and looks forward to welcoming them again in Lisbon for CIRSE 2015!
Aachen Resonance
Abbott Vascular
ALN Implants Chirurgicaux
Alvimedica
Andramed
Angiodroid
AngioDynamics
AprioMed
ArraVasc
ArtVentive Medical
Austrian Society of Interventional Radiology (ÖGIR)
Bard
Bayer Pharma
Bentley InnoMed
Bioteque
Biotronik
BK Medical / Analogic Ultrasound
Bolton Medical
Boston Scientific
British Institute of Radiology (BIR)
British Society of Interventional Radiology (BSIR)
BTG
CareFusion
CAScination
CeloNova BioSciences
Clinical Laserthermia Systems
Cook Medical
Cordis Johnson & Johnson Medical
Covidien
Creagh Medical
German Society of Interventional Radiology (DEGIR)
Deutsche Akademie für Mikrotherapie (DAfMT)
DFine
Edizioni Minerva Medica
Endovascular Today
Galil Medical
Galt Medical
GEM
GO Medical
Greek / Hellenic Society of Interventional Radiology (GSIR)
Guerbet
H.S. Hospital Service
Hansen Medical
HealthManagement
Hyprevention
Imactis
Imedicom
InSightec
Interventional News / BIBA
Korean Society of Interventional Radiology (KSIR)
Lemer Pax
LINC 2015
Lombard Medical
MDT X-Ray
Medcomp
Medical Professionals
Medtronic
Mentice
Merit Medical
Möller Medical
NeuWave
Olympus Surgical Technologies
Optimed Medizinische Instrumente
Oscor
Pajunk
Pan Medical
Penumbra
Perfint Healthcare
Perouse Medical
PharmaCept
Philips Healthcare
QualiMed Innovative Medizinprodukte
Reverse Medical
RF Medical
Seldinger Society for Vascular and Interventional Radiology (SSVIR)
Siemens
Simbionix
Sirtex Medical
Society of Interventional Radiology (SIR)
St. Jude Medical
Sterylab
Straub Medical
Surefire Medical
Tecres
Teleflex Medical
TeraRecon
Terumo
Tokai Medical Products
Toshiba Medical Systems
Turkish Society of Interventional Radiology (TSIR)
UreSil
Vascular Solutions
Veniti
Volcano
W.L. Gore & Associates
Wisepress Medical Bookshop
3D print EVAR study / Southend Hospital
61
62
Destination Lisbon
Explore IR in Lisbon
As the city that launched the Age of Discovery, Lisbon
is a fitting location in which to discover the latest
breakthroughs in minimally invasive image-guided
medicine.
More information about participating airlines can
be found on page 64, and on the CIRSE website
(www.cirse.org/flights). Please quote the discount
code TP10S15 when booking.
CIRSE has visited this "city of light" in 2009 and 2012,
and the success of both congresses means we are
looking forward to enjoying the many benefits of this
welcoming and well-connected city once more.
Our venue
The congress centre, Centro de Congressos de Lisboa,
offers us sufficient room for our many sessions, workshops and our extensive exhibition, as well as excellent
facilities for our expected 6,000 delegates. Located in
the parish of Belém, just 6 km south-west of the city
centre, it lies within easy reach of many hotels.
Getting there
As the sunshine capital of Europe, Lisbon enjoys
excellent flight connections, ferrying both tourists and
business travellers from around the world with ease.
Lisbon is served by Lisbon Portela Airport (Aeroporto
da Portela), located 7 km north of the city centre.
As one of the largest and best-equipped airports in
Southern Europe, it has been nominated as Europe’s
Leading Airport for six consecutive years in the World
Travel Awards, as well as having played a starring role
in the classic film, Casablanca.
The national carrier, TAP Portugal, has the airport as
its main base, and it is a focus city for budget carriers Easy Jet and Ryanair. This offers congress-goers
excellent flight connections to a wide range of
destinations. Recently refurbished, the airport is now
connected to the city’s extensive metro network.
© [email protected]
As part of the Schengen area, most European visitors
require no visa to enter. Similarly, agreements with
Australia, Canada, Israel, Japan, the USA and a number
of other countries mean that delegates from these
countries need only provide a passport valid for at
least three months after the end of their stay (provided
this stay is of less than 90 days’ duration). More details
are available from your local Portuguese embassy or
consulate, or one of their websites.
Belém, a name derived from the Portuguese for
Bethlehem, was one of the few parts of Lisbon to
survive the 1755 earthquake, and thus features some
of the oldest buildings in the city. It was also the port
used to launch many of the voyages of discovery,
including Vasco da Gama’s 1497 mission to India.
Both these historical facts are embodied by the iconic
Belém Tower, a stately Manueline lighthouse that
guards the entrance to the port.
Save on your flight!
CIRSE has negotiated a special deal with the Star
AllianceTM network, allowing registered CIRSE 2015
participants to benefit from a discount of up to 20%
on their flights, depending on the fare and class of
travel booked.
The tower also served to guard the nearby Jerónimos
Monastery, built as a monument to da Gama’s successful voyage to India, and later housing the explorer’s
tomb. The monastery is also famous for creating the
original Pastéis de nata, and seemingly the best ones
can still be bought in the local Fábrico dos Pastéis de
Belém.
C RSE
Lisbon 2015
Destination Lisbon
Getting about
Lisbon’s public transport system is reliable and wellplanned. The metro forms the main skeleton of the
network, with buses, trams and funicular services filling in the gaps. The trams of Lisbon are particularly
worth a trip – originally introduced in the 19th century from the USA, these little yellow wonders were
dubbed "americanos". The small, old-fashioned carriages are perfectly suited to Lisbon’s steep hills and
narrow streets, and have become one of the icons of
modern Lisbon.
What to eat
While the congress will be an intense affair, offering
sessions and learning opportunities from 08:00 until
18:00, Lisbon offers lots of opportunity to unwind in
the evening. With an amazing 1,800 km of coastline at
their disposal, it is not surprising that Portuguese cuisine incorporates the finest seafood.
White cod (or bacalhau) is by far the most popular.
Legend has it that such a vast variety of bacalhau recipes exist, that you could eat it every day of the year
without ever repeating a recipe.
© traveltrade
Portugal is also noted for Port wine from the Douro
region, which is one of the oldest wine regions of
Europe. Olives are another local specialty, as are Pastéis
de nata – delicious little custard-pastries, over which
cinnamon and icing sugar is shaken.
Gaby [email protected]
Where to stay
Our official travel partners, Kuoni Destination
Management and Buzz Portugal DMC, have plenty
of accommodation and travel suggestions to make,
and further details and a useful map can be found on
pages 65-67. Kuoni is also offering group booking,
making it easier for national society delegations to
find accommodation together.
The sound of the sea permeates more than their cuisine, however, and all visitors to Portugal should try
to experience traditional Fado music. Fado (fate or
destiny) can be about anything, but the sea and nostalgia for those who are far away upon it are common
themes.
More ideas on how to recharge in the evening can be
found at www.visitlisbao.com.
Come explore the world of IR with us in Lisbon!
63
64
Lisbon 2015
Accommodation
Accommodation
In co-operation with its travel partners KUONI Destination
Management and Buzz Portugal DMC, CIRSE has secured a
great number of hotel rooms in Lisbon for the benefit of our
congress participants.
CANCELLATION POLICY (Individual bookings)
If you have any questions, please do not hesitate to contact:
Buzz Portugal DMC
Claudia Rothe, Project Manager
Av. Elias Garcia, 147 – 5º Esq :: 1050-099 Lisboa
Phone: +351 211 147 160
Cancellations between June 2, 2015 and July 18, 2015:
50% refund less a handling fee of €25 (EUR).
Individual bookings:
The hotels and rates offered overleaf can be used for individual
bookings (up to and including 9 rooms) only. CIRSE supports
compliance with ethical standards, and therefore emphasises
that the participants shall bear any and all costs in this context
themselves.
No shows: Your hotel room will be cancelled after first night
of no show and the full amount of your stay will be charged
automatically.
Online hotel reservation is now available at
www.cirse.org/accommodation
All cancellations and changes are to be addressed to Buzz
Portugal DMC in writing.
Group Bookings (10 rooms and more):
Special booking conditions may apply. Please contact Buzz
Portugal DMC via Email or phone.
Please note that accommodation for additional nights is strictly
subject to the hotel’s availability.
All necessary refunds will be made after the congress.
Cancellations until June 1, 2015:
100% refund less a handling fee of €25 (EUR).
Cancellations received after July 19, 2015:
No refund can be made, 100% cancellation fee will apply on
the full stay.
Early Departure: Guests will be charged in full for checking out
prior to the departure date confirmed.
Buzz Portugal and Kuoni shall act as mediators only and
cannot be held responsible for any loss incurred or any
damage inflicted on persons or objectives irrespective of
whatsoever cause. Only written agreements shall be valid.
The place of jurisdiction shall be Vienna.
65
66
Accommodation
Hotel List CIRSE 2015 Lisbon
Hotel Name
5* Hotels
Price per Night
(€)
Location area
Travel time
public
transport
Travel
time
taxi
5* Hotels
01
02
03
04
05
06
07
08
09
10
11
12
Altis Avenida
Altis Belém
Altis Grand
Dom Pedro Palace
Epic Sana Lisbon
Olissippo Lapa Palace
Pestana Palace
Porto Bay Liberdade
Real Palácio
Sheraton Lisboa*
Tivoli Lisboa
VIP Grand Lisboa Hotel & Spa*
260
300
270
250
260
360
315
205
240
200
295
150
City centre south
South of Lisbon
City centre south
City centre south
City centre south
South of Lisbon
South of Lisbon
City centre south
City centre south
City centre south
City centre south
City centre north
20 min.
25 min.
20 min.
30 min.
18 min.
20 min.
8 min. walking
20 min.
22 min.
30 min.
20 min.
34 min.
15 min.
10 min.
15 min.
12 min.
12 min.
5 min.
5 min.
15 min.
15 min.
15 min.
15 min.
15 min.
135
240
240
189
215
290
130
130
245
250
170
260
240
195
210
135
180
180
110
150
130
180
230
195
150
200
255
165
150
230
90
85
90
130
150
105
City centre south
City centre south
City centre south
City centre south
City centre south
City centre south
City centre north
City centre north
City centre north
South of Lisbon
City centre north
City centre south
City centre north
City centre north east
City centre south
City centre north
City centre north
City centre north
City centre north
North east of Lisbon
North of Lisbon
City centre north
City centre south
City centre north
City centre north
City centre south
City centre south
South of Lisbon
City centre south
City centre north
City centre north
City centre north
City centre south
27 min.
25 min.
20 min.
25 min.
30 min.
20 min.
31 min.
38 min.
32 min.
12 min.
34 min.
15 min.
41 min.
30 min.
20 min.
15 min.
32 min.
25 min.
35 min.
55 min.
37 min.
23 min.
20 min.
25 min.
39 min.
20 min.
20 min.
35 min.
35 min.
5 min. walking
35 min.
18 min.
30 min.
33 min.
36 min.
30 min.
12 min.
15 min.
15 min.
16 min.
16 min.
15 min.
15 min.
15 min.
15 min.
8 min.
15 min.
10 min.
15 min.
15 min.
10 min.
11 min.
10 min.
10 min.
15 min.
25 min.
15 min.
15 min.
15 min.
12 min.
15 min.
15 min.
15 min.
20 min.
20 min.
5 min. walking
20 min.
15 min.
10 min.
10 min.
10 min.
15 min.
160
155
155
155
70
City centre south
City centre north
City centre north
City centre south
City centre north
15 min.
35 min.
35 min.
17 min.
36 min.
10 min.
11 min.
12 min.
10 min.
10 min.
4* Hotels
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
Açores Lisboa
Altis Prime
Altis Suites
Exe Lisboa Parque
Fontana Park
Heritage Av. Liberdade
Holiday Inn Continental
Holiday Inn Lisboa
Inspira Santa Marta
Jeronimos 8
Júpiter Lisboa
Lisboa Plaza
Lisbon Marriott
Lutécia
Lux Lisboa Park
Marquês de Pombal
Mercure Lisboa
Novotel Lisboa
Olissippo Marquês de Sá
Olissippo Oriente
Radisson Blu
Real Parque
Sana Lisboa
Sana Malhoa
Sana Metropolitan
Skyna Lisboa
Tivoli Jardim
Tivoli Oriente
Tryp Lisboa Aeroporto
Vila Galé Ópera
Vip Executive Art’s*
Vip Executive Suites Marquês*
Vip Executive Villa Rica*
3K Barcelona
3K Europa
3K Madrid
3* Hotels
49
50
51
52
53
Sana Capitol
Sana Executive
Sana Reno
Sana Rex
Vip Executive Zurique*
* Special rate valid until March 15th, 2015
City Map and Hotels
Lisbon 2015
67
41
43
40
32
33
25
37
29 36 13
30
26
45
47
5312
19
46
23
20
3150
51
34 10 17
9
38
16 44
27 52
35 48
49
4 5
8 28 21
15 3 11
14 39
24 18
1
6
7
22
2
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
Altis Avenida
Altis Belém
Altis Grand
Dom Pedro Palace
Epic Sana Lisboa
Olissippo Lapa Palace
Pestana Palace
Porto Bay Liberdale
Real Palácio
Sheraton Lisboa
Tivoli Lisboa
Vip Grand Lisboa Hotel & Spa
Açores Lisboa
Altis Prime
Altis Suites
Exe Lisboa Parque
Fontana Park
Heritage Av. Liberdade
***** Hotel
**** Hotel
*** Hotel
42
Congress Centre
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
Holiday Inn Continental
Holiday Inn Lisboa
Inspira Santa Marta
Jerónimos 8
Júpiter Lisboa
Lisboa Plaza
Lisbon Marriott
Lutécia
Lux Lisboa Park
Marquês de Pombal
Mercure Lisboa
Novotel Lisboa
Olissippo Marquês de Sá
Olissippo Oriente
Radisson Blu
Real Parque
Sana Lisboa
Sana Malhoa
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
Sana Metropolitan
Skyna Lisboa
Tivoli Jardim
Tivoli Oriente
Tryp Lisboa Aeroporto
Vila Galé Ópera
Vip Executive Art’s
Vip Suites do Marquês
Vip Executive Villa Rica
3K Barcelona
3K Europa
3K Madrid
Sana Capitol
Sana Executive
Sana Reno
Sana Rex
Vip Executive Zurique
Our local travel partners Buzz Portugal DMC and Kuoni Destination
Management will be more than pleased to assist you with your hotel bookings.
Please contact them via email at [email protected].
Detailed information about hotels and rates as well as an online booking
service are available at www.cirse.org.
68
Notes
C RSE
Lisbon 2015
Notes
69

Brochure

Transcrição

Documentos relacionados

Bio

Rosário Durão

Lisbon - APPT21

Rosário Durão

IFSA-EUSFLAT 2009 Proceedings

Endovascular treatment of abdominal aortic aneurysms in

Alterations of blood flow pattern after triple stent endovascular

Meet the stars from Portugal

FUC

Session: Workforce Scheduling Set Covering

Account holder: Fundação da Faculdade de Ciências

practice

Parque das Nações - POSTED TO PORTUGAL

Differences between systolic and diastolic dimensions of the aortic

Henri Justino MD, CM, FRCPC, FACC, FSCAI, FAAP

Simplified method for esophagus protection during radiofrequency

13 - Cardiovascular Sciences Forum